{"id":2634,"date":"2020-04-08T23:00:22","date_gmt":"2020-04-08T15:00:22","guid":{"rendered":"https:\/\/geneusmtc.com\/?page_id=2634"},"modified":"2021-05-14T09:55:06","modified_gmt":"2021-05-14T01:55:06","slug":"%e5%81%a5%e5%ba%b7%e5%85%88%e7%9f%a5","status":"publish","type":"page","link":"https:\/\/geneusmtc.com\/service\/%e5%81%a5%e5%ba%b7%e5%85%88%e7%9f%a5\/","title":{"rendered":""},"content":{"rendered":"<p><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"background-color: rgba(255,255,255,0);background-position: left top;background-repeat: no-repeat;padding-top:100px;padding-right:0px;padding-bottom:75px;padding-left:0px;margin-bottom: 0px;margin-top: 0px;border-width: 0px 0px 0px 0px;border-color:#eae9e9;border-style:solid;\" ><div class=\"fusion-builder-row fusion-row\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last\" style=\"margin-top:0px;margin-bottom:0px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;background-color:#ffffff;border-width: 0px 0px 0px 0px;border-color:#dddddd;border-style:solid;padding: 0px 20px 0px 20px;\"><div class=\"fusion-text fusion-text-1\"><h2><strong>\u5065\u5eb7\u5148\u77e5 (\u9032\u968e\u7248)<\/strong><\/h2>\n<\/div><div class=\"fusion-text fusion-text-2\"><p style=\"padding-left: 40px;\">\u5065\u5eb7\u5148\u77e5\u9032\u968e\u7248\u5305\u542b\u907a\u50b3\u6027\u764c\u75c7 (49\u57fa\u56e0)\u3001\u5fc3\u8840\u7ba1\u75be\u75c5 (152\u57fa\u56e0)\u3001\u7d50\u7de0\u7d44\u7e54 (56\u57fa\u56e0)\u3001\u7cd6\u5c3f\u75c5\u548c\u80a5\u80d6\u53ca\u4ee3\u8b1d\u6027\u75be\u75c5 (38\u57fa\u56e0)\u3001\u8996\u89ba\u53ca\u807d\u89ba (10\u57fa\u56e0)\u3001\u907a\u50b3\u6027\u75be\u75c5 (21\u57fa\u56e0)\uff0c\u8a73\u7d30\u57fa\u56e0\u53c3\u898b\u9644\u8868\u3002\u672c\u6aa2\u6e2c\u670d\u52d9\u63d0\u4f9b\u5ba2\u6236\u5c0d\u65bc\u4e0a\u8ff0\u985e\u5225\u7684\u75be\u75c5\u7684\u57fa\u56e0\u98a8\u96aa\u8a55\u4f30\uff0c\u900f\u904eDNA\u5e8f\u5217\u5206\u6790\uff0c\u6bd4\u5c0d\u6676\u6e96\u5408\u4f5c\u5be6\u9a57\u5ba4\u7684\u5ee3\u5927\u8cc7\u6599\u5eab\uff0c\u767c\u73fe\u57fa\u56e0\u4e2d\u53ef\u80fd\u81f4\u75c5\u7684\u7a81\u8b8a\uff0c\u63d0\u65e9\u9810\u8b66\uff0c\u4e26\u8207\u5c08\u696d\u91ab\u7642\u4eba\u54e1\u8aee\u8a62\uff0c\u907f\u514d\u7f79\u75c5\u6216\u6e1b\u5c11\u60a3\u75c5\u6642\u7684\u56b4\u91cd\u5ea6\u3002<\/p>\n<p style=\"padding-left: 40px;\">\u64da\u4e16\u754c\u885b\u751f\u7d44\u7e54\u7d71\u8a08\uff0c\u5168\u7403\u6bcf\u5206\u9418\u670918\u4eba\u6b7b\u65bc\u764c\u75c7\uff0c\u885b\u751f\u798f\u5229\u90e8\u4e5f\u516c\u544a\u764c\u75c7\u70ba\u570b\u4eba\u5341\u5927\u6b7b\u56e0\u4e4b\u9996\uff0c\u5148\u524d\u7814\u7a76\u986f\u793a\u6240\u6709\u764c\u75c7\u4e2d14.6%\u7684\u75c5\u60a3\u6709\u5bb6\u65cf\u53f2\u3002\u7f8e\u570b\u81e8\u5e8a\u816b\u7624\u91ab\u5b78\u6703\u8868\u793a\uff0c\u90e8\u5206\u55ae\u57fa\u56e0\u767c\u751f\u81f4\u75c5\u6027\u8b8a\u7570 (\u5982TP53\u3001BRCA1\/BRCA2)\uff0c\u6703\u5c0e\u81f4\u4e2d\u9ad8\u5ea6\u7f79\u764c\u98a8\u96aa\u3002\u56e0\u6b64\u7d93\u7531\u57fa\u56e0\u5206\u6790\uff0c\u53ef\u9810\u5148\u4e86\u89e3\u53ef\u80fd\u7f79\u764c\u7684\u90e8\u4f4d\uff0c\u4f86\u9032\u884c\u9810\u9632\u6027\u7684\u91ab\u7642\u8655\u7f6e\uff0c\u6e1b\u5c11\u764c\u75c7\u672b\u671f\u624d\u767c\u73fe\u6642\u7684\u9f90\u5927\u91ab\u85e5\u8cbb\u53ca\u589e\u52a0\u764c\u75c7\u6cbb\u7642\u6210\u529f\u7387\u3002<\/p>\n<p style=\"padding-left: 40px;\">\u5fc3\u8840\u7ba1\u75be\u75c5\u5728\u53f0\u7063\u6392\u540d\u5341\u5927\u6b7b\u56e0\u7b2c\u4e8c\uff0c\u5728\u773e\u591a\u7684\u5371\u96aa\u56e0\u5b50\u4e2d\u907a\u50b3\u57fa\u56e0\u3001\u7a2e\u65cf\u3001\u9ad8\u9f61\u662f\u4e0d\u53ef\u6539\u8b8a\u7684\u30021%\u7684\u65b0\u751f\u5152\u6709\u5148\u5929\u6027\u5fc3\u81df\u75c5\uff0c\u800c\u7576\u4e2d\u67091\/4\u6703\u6709\u56b4\u91cd\u7684\u75c7\u72c0\u3002\u6240\u8b02\u5148\u5929\u6027\u5fc3\u8840\u7ba1\u75be\u75c5\uff0c\u5728\u51fa\u751f\u6642\u5c31\u6709\u5fc3\u81df\u7d50\u69cb\u6216\u529f\u80fd\u65b9\u9762\u7684\u7f3a\u9677\uff0c\u9019\u4e9b\u7f3a\u9677\u901a\u5e38\u767c\u751f\u5728\u5fc3\u81df\u7684\u808c\u8089\u3001\u74e3\u819c\u6216\u662f\u52d5\u8108\uff0c\u96d6\u7136\u5728\u521d\u671f\u75c5\u4eba\u9084\u7b97\u5065\u5eb7\uff0c\u4f46\u65e5\u5f8c\u529f\u80fd\u8870\u9000\u3001\u8840\u6db2\u542b\u6c27\u4e0d\u8db3\uff0c\u81e8\u5e8a\u4e0a\u5e38\u53ef\u89c0\u5bdf\u5230\u547c\u5438\u6025\u4fc3\u3001\u5fc3\u81df\u6709\u96dc\u97f3\u3001\u76ae\u819a\u767c\u7d3a\u3002\u5982\u679c\u672a\u6cbb\u7642\uff0c\u53ef\u80fd\u5c0e\u81f4\u4f11\u514b\u660f\u8ff7\u751a\u81f3\u6b7b\u4ea1\u3002<\/p>\n<p style=\"padding-left: 40px;\">\u5df2\u77e5\u6709200\u7a2e\u4ee5\u4e0a\u7684\u907a\u50b3\u6027\u969c\u7919\u5f71\u97ff\u7d44\u7e54\u53ca\u7d30\u80de\u7684\u5f62\u6210\u53ca\u7d44\u7e54\u548c\u7d30\u80de\u9593\u7684\u9375\u7d50\u5f37\u5ea6\uff0c\u800c\u9019\u985e\u578b\u7684\u907a\u50b3\u6027\u969c\u7919\u5c31\u662f\u52d5\u8108\u53ca\u7d50\u7de0\u7d44\u7e54\u75c5\u8b8a\uff0c\u800c\u4e14\u6210\u56e0\u90fd\u662f\u57fa\u56e0\u8b8a\u7570\uff0c\u9019\u985e\u578b\u7684\u8b8a\u7570\u5e38\u6703\u5f71\u97ff\u500b\u9ad4\u7684\u5916\u89c0\u53ca\u76ae\u819a\u3001\u9aa8\u9abc\u3001\u95dc\u7bc0\u3001\u5fc3\u81df\u3001\u8840\u7ba1\u3001\u80ba\u3001\u773c\u775b\u3001\u8033\u6735\u7684\u751f\u9577\uff0c\u4e5f\u6703\u907a\u50b3\u7d66\u4e0b\u4e00\u4ee3\u3002<\/p>\n<p style=\"padding-left: 40px;\">\u9020\u6210\u7cd6\u5c3f\u75c5\u53ca\u80a5\u80d6\u73fe\u8c61\u5177\u6709\u8907\u96dc\u7684\u539f\u56e0\uff0c\u5305\u62ec\u591a\u57fa\u56e0\u907a\u50b3\u3001\u751f\u6d3b\u578b\u614b\u548c\u74b0\u5883\u56e0\u7d20\u3002\u5728\u90e8\u5206\u7684\u60c5\u6cc1\uff0c\u7cd6\u5c3f\u75c5\u53ca\u80a5\u80d6\u53ef\u80fd\u662f\u55ae\u57fa\u56e0\u8b8a\u7570\u6240\u9020\u6210\u3002\u7b2c\u4e8c\u578b\u7cd6\u5c3f\u75c5\u662f\u76ee\u524d\u5df2\u77e5\u6700\u5e38\u898b\u7684\u4ee3\u8b1d\u75be\u75c5\uff0c\u5168\u4e16\u754c\u7d04\u67095%\u7684\u4eba\u6709\u7b2c\u4e8c\u578b\u7cd6\u5c3f\u75c5\uff0c\u6700\u91cd\u5e38\u9020\u6210\u5931\u660e\u3001\u622a\u80a2\u53ca\u814e\u75c5\u3002\u76ee\u524d\u7b2c\u4e8c\u578b\u7cd6\u5c3f\u75c5\u7684\u7814\u7a76\u4ee5 MODY (Maturity Onset Diabetes of the Young)\u6709\u660e\u986f\u7684\u8868\u73fe\u578b\uff0c\u901a\u5e38\u572825\u6b72\u524d\u6703\u767c\u75c5\uff0c\u800c\u4e14\u8207\u907a\u50b3\u7684\u95dc\u4fc2\u76f8\u7576\u660e\u78ba\u3002<\/p>\n<p style=\"padding-left: 40px;\">\u8996\u7db2\u819c\u75c5\u8b8a\u4e2d\u6709\u540d\u7684\u75be\u75c5-\u907a\u50b3\u6027\u8996\u7db2\u819c\u5931\u990a\u75c7\uff0c\u5176\u4e2d\u6700\u5e38\u898b\u7684\u8996\u7db2\u819c\u8272\u7d20\u8b8a\u6027(retinitis pigmentosa)\uff0c\u76db\u884c\u7387\u7d04\u70ba\u4e00\u5343\u5206\u4e4b\u4e00\uff0c\u6709\u9ad8\u5ea6\u907a\u50b3\u907a\u50b3\u6027\uff0c\u75c7\u72c0\u591c\u76f2\u3001\u8996\u89ba\u969c\u7919\u3001\u8fa8\u8272\u529b\u4e0b\u964d\u3001\u8996\u91ce\u72f9\u7a84\u3002\u5375\u9ec3\u72c0\u9ec3\u6591\u71df\u990a\u4e0d\u826f\uff0c\u53ef\u5c0e\u81f4\u9032\u884c\u6027\u8996\u529b\u6e1b\u9000\uff0c\u6703\u5f71\u97ff\u5230\u8996\u7db2\u819c(\u8996\u7db2\u819c\u662f\u896f\u5728\u773c\u5f8c\u7684\u5c08\u9580\u611f\u5149\u7684\u7d44\u7e54)\u3002\u9ec3\u6591\u8ca0\u8cac\u6e05\u6670\u7684\u4e2d\u592e\u8996\u529b\uff0c\u9019\u662f\u95b1\u8b80\uff0c\u99d5\u99db\u548c\u8b58\u5225\u9762\u90e8\u7b49\u8a73\u7d30\u4efb\u52d9\u6240\u5fc5\u9700\u7684\u3002\u5982\u679c\u5728\u6210\u5e74\u671f\u767c\u4f5c\u7684\u5f62\u5f0f\u901a\u5e38\u5728\u6210\u5e74\u5f8c\u671f\uff0c\u4e26\u5f80\u5f80\u5c0e\u81f4\u8996\u529b\u55aa\u5931\uff0c\u4e26\u96a8\u8457\u6642\u9593\u7684\u63a8\u79fb\u9010\u6f38\u60e1\u5316\u3002<\/p>\n<p style=\"padding-left: 40px;\">\u4f9d\u64da\u4e16\u754c\u885b\u751f\u7d44\u7e54\u5831\u544a\uff0c\u5168\u4e16\u754c\u67094.66\u5104\u4eba\u6709\u807d\u529b\u969c\u7919\u7684\u554f\u984c\uff0c\u800c\u5176\u4e2d\u67093400\u842c\u70ba\u5152\u7ae5\uff0c\u4f30\u8a08\u81f32050\u5e74\u5c07\u6709\u5168\u7403\u5c07\u67099\u5104\u4eba\u6709\u807d\u529b\u969c\u7919\u7684\u554f\u984c\u300265\u6b72\u4ee5\u4e0a\u7684\u8001\u4eba\u67093\u5206\u4e4b\u4e00\u6709\u807d\u529b\u969c\u7919\u3002\u807d\u529b\u969c\u7919\u6709\u53ef\u80fd\u56e0\u70ba\u907a\u50b3\u3001\u611f\u67d3\u3001\u85e5\u7269\u53ca\u9577\u671f\u8655\u65bc\u566a\u97f3\u4e0b\u5f15\u8d77\u3002\u5728\u907a\u50b3\u6027\u7684\u807d\u529b\u969c\u7919\u4e2d\uff0c\u670930%\u662f\u4f34\u96a8\u5176\u4ed6\u75c7\u72c0\uff0c\u4f46\u662f\u591a\u657870%\u70ba\u7121\u4f34\u96a8\u75c7\u72c0\uff0c\u800c\u4e14\u6703\u96a8\u5e74\u9f61\u9010\u6f38\u60e1\u5316\u3002<\/p>\n<p style=\"padding-left: 40px;\">\u5728\u5065\u5eb7\u5148\u77e5\u6aa2\u6e2c\u9805\u76ee\u4e2d\uff0c\u6211\u5011\u7279\u5225\u7684\u9078\u51fa\u6578\u7a2e\u5176\u4ed6\u985e\u5225\u907a\u50b3\u6027\u75be\u75c5\uff0c\u800c\u6700\u6709\u540d\u7684\u5305\u62ec\u942e\u5200\u578b\u8ca7\u8840\u53ca\u6953\u7cd6\u5c3f\u75c7\u3002\u942e\u5200\u578b\u8ca7\u8840\u53c8\u7a31\u5730\u4e2d\u6d77\u8ca7\u8840\uff0c\u9867\u540d\u601d\u7fa9\u5c31\u662f\u7d05\u8840\u7403\u5448\u73fe\u942e\u5200\u578b\u3002\u6b63\u5e38\u7d05\u8840\u7403\u58fd\u547d\u7d0490\uff5e120\u5929\uff0c\u942e\u5200\u578b\u7d05\u8840\u7403\u7684\u58fd\u547d\u5247\u523020\u5929\u4ee5\u4e0b\uff0c\u4e5f\u5c6c\u65bc\u6eb6\u8840\u6027\u8ca7\u8840\uff08hemolytic anemia\uff09\u3002\u63a7\u5236\u7684\u57fa\u56e0\u4f4d\u5728\u4eba\u985e\u7b2c11\u689d\u67d3\u8272\u9ad4\u4e0a\uff0c \u76ee\u524d\u53ef\u4ee5\u900f\u904e\u907a\u50b3\u8aee\u8a62\uff0c\u964d\u4f4e\u751f\u4e0b\u942e\u5200\u578b\u8ca7\u8840\u65b0\u751f\u5152\u7684\u6a5f\u6703\u3002\u75c7\u72c0\u6839\u64da\u4e0d\u540c\u985e\u578b\u6709\u4e0d\u540c\u7684\u56b4\u91cd\u5ea6\uff0c\u9664\u4e86\u8ca7\u8840\u75c7\u72c0\uff0c\u5026\u6020\u611f\uff0c\u819a\u8272\u84bc\u767d\uff0c\u6709\u6642\u5408\u4f75\u6709\u813e\u81df\u816b\u5927\uff0c\u5728\u98f2\u98df\u65b9\u9762\u56e0\u70ba\u9435\u96e2\u5b50\u6c89\u7a4d\u75c7\uff0c\u6240\u4ee5\u61c9\u53d6\u7528\u4f4e\u9435\u8cea\u98f2\u98df\u3002<\/p>\n<p style=\"padding-left: 40px;\">\u5176\u4ed6\u5982\u6953\u7cd6\u5c3f\u75c7\uff08maple syrup urine disease\uff09\u4e5f\u5728\u6aa2\u6e2c\u9805\u76ee\u4e2d\u3002\u60a3\u8005\u7684\u9ad4\u3001\u5c3f\u6db2\u6709\u6953\u7cd6\u6f3f\u5473\uff0c\u662f\u6700\u5e38\u767c\u751f\u5728\u539f\u4f4f\u6c11\u65cf\u7fa4\u7684\u4ee3\u8b1d\u7570\u5e38\u75be\u75c5\uff0c\u7f55\u898b\u75be\u75c5\u57fa\u56e0\u6703\u638c\u63e1\u7684\u6848\u4f8b\u4e2d\uff0c\u5c31\u670970%\u4ee5\u4e0a\u70ba\u539f\u4f4f\u6c11\u5b69\u5b50\u3002\u7531\u65bc\u9ad4\u5167\u7f3a\u5c11\u652f\u93c8\u7532\u578b\u916e\u9178\u812b\u6c2b\u9176\u7d20(branched-chain \u03b1-keto acid dehydrogenase)\uff0c\u4f7f\u5f97\u652f\u93c8\u80fa\u57fa\u9178\u7121\u6cd5\u9032\u884c\u53bb\u7fa7\u57fa\u53cd\u61c9\uff08decarboxylation\uff09\uff0c\u56e0\u800c\u652f\u93c8\u80fa\u57fa\u9178\uff08\u7e88\u80fa\u9178\u3001\u767d\u80fa\u9178\u3001\u7570\u767d\u80fa\u9178\uff09\u5806\u7a4d\u5728\u9ad4\u5167\u7522\u751f\u6bd2\u6027\uff0c\u4f7f\u8166\u640d\u50b7\uff0c\u4e5f\u7522\u751f\u4e86\u7279\u6b8a\u7684\u9ad4\u5473\uff0c\u5c6c\u65bc\u9ad4\u67d3\u8272\u9ad4\u96b1\u6027\u907a\u50b3\u75be\u75c5\uff0c\u901a\u5e38\u7f79\u60a3\u6b64\u75c7\u7684\u5b30\u5152\uff0c\u5728\u958b\u59cb\u9935\u98df\u5f8c\u6578\u5929\u9010\u6f38\u51fa\u73fe\u5614\u5410\u3001\u55dc\u7761\u3001\u98df\u617e\u6e1b\u4f4e\u3001\u547c\u5438\u6025\u4fc3\u3001\u9ec3\u75b8\u3001\u62bd\u6410\u7b49\u73fe\u8c61\uff0c\u56e0\u6b64\u9577\u671f\u9700\u7279\u6b8a\u5976\u7c89\u9069\u7576\u7ba1\u5236\u75c5\u60a3\u5c0d\u5206\u652f\u93c8\u80fa\u57fa\u9178\u7684\u651d\u53d6\u3002<\/p>\n<p style=\"padding-left: 40px;\">\u6280\u8853\u6458\u8981<\/p>\n<p style=\"padding-left: 40px;\">\u6211\u5011\u4f7f\u7528\u6b21\u4e16\u4ee3\u5b9a\u5e8f\u65b9\u6cd5\u89e3\u6790\u57fa\u56e0\u5e8f\u5217\uff0c\u6280\u8853\u7684\u654f\u611f\u6027\u548c\u7279\u7570\u6027\u9ad8\u905499%\u3002\u9019\u500b\u6aa2\u6e2c\u7684\u5e73\u5747\u8986\u84cb\u6df1\u5ea6 &gt; 100X\u4e1498%\u7684\u76ee\u6a19\u5340\u7684\u8986\u84cb\u7387 &gt;= 10X\u3002\u9019\u500b\u57fa\u56e0\u6aa2\u6e2c\u5957\u4ef6\u4f7f\u7528Atlas-CNV\u65b9\u6cd5\u5075\u6e2c\u5927\u7247\u6bb5\u7684\u7f3a\u5931\u53ca\u91cd\u8907(CNVs)<\/p>\n<\/div><style type=\"text\/css\"><\/style><div class=\"fusion-title title fusion-title-1 fusion-sep-none fusion-title-text fusion-title-size-one\" style=\"margin-top:0px;margin-right:0px;margin-bottom:0px;margin-left:0px;\"><h1 class=\"title-heading-left fusion-responsive-typography-calculated\" style=\"margin:0;--fontSize:80;line-height:1;\"><h2><\/h2>\n<h2 style=\"text-align: center;\">\u907a\u50b3\u6027\u764c\u75c7<\/h2>\n<h2><\/h2><\/h1><\/div>\n<div class=\"table-1\">\n<table style=\"height: 4352px;\" width=\"1088\">\n<tbody>\n<tr>\n<td width=\"85\">\u57fa\u56e0\u540d<\/td>\n<td width=\"425\">\u76f8\u95dc\u764c\u75c7<\/td>\n<td width=\"158\">\u76f8\u95dc\u764c\u75c7\u4e2d\u6587<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">APC<\/td>\n<td width=\"425\">Colorectal cancer somatic, Gastric cancer somatic Adenomatous polyposis coli, Brain tumor- polyposis syndrome 2, Gardner syndrome, Desmoid disease hereditary, Hepatoblastoma somatic<\/td>\n<td width=\"158\">\u5927\u8178, \u80f0\u81df<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">ATM<\/td>\n<td width=\"425\">Breast cancer susceptibility, Prostate cancer susceptibility, Pancreatic cancer susceptibility, Ataxia- telangiectasia<\/td>\n<td width=\"158\">\u4e73\u623f, \u80f0\u81df<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">BAP1<\/td>\n<td width=\"425\">Tumor predisposition syndrome<\/td>\n<td width=\"158\">\u9ed1\u8272\u7d20<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">BARD1<\/td>\n<td width=\"425\">Breast cancer, susceptibility<\/td>\n<td width=\"158\">\u4e73\u623f<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">BMPR1A<\/td>\n<td width=\"425\">Colorectal cancer, Pancreatic cancer susceptibility, Juvenile polyposis syndrome infantile form, Polyposis syndrome hereditary mixed 2, Polyposis juvenile intestinal<\/td>\n<td width=\"158\">\u5927\u8178, \u80f0\u81df, \u80c3<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">BRCA1<\/td>\n<td width=\"425\">Breast-ovarian cancer familial 1, Pancreatic cancer susceptibility, Prostate cancer susceptibility, Fanconi anemia complementation group S<\/td>\n<td width=\"158\">\u4e73\u623f, \u5375\u5de2, \u80f0\u81df, \u524d\u5217\u817a<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">BRCA2<\/td>\n<td width=\"425\">Breast-ovarian cancer, Breast cancer male susceptibility, Breast cancer Fanconi anemia complementation group D1, Glioblastoma 3, Medulloblastoma, Pancreatic cancer 2, Prostate cancer, Wilms tumor<\/td>\n<td width=\"158\">\u4e73\u623f, \u5375\u5de2, \u9ed1\u8272\u7d20, \u80f0\u81df, \u80c3, \u524d\u5217\u817a<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">BRIP1<\/td>\n<td width=\"425\">Breast cancer, early-onset, susceptibility to<\/td>\n<td width=\"158\">\u4e73\u623f, \u5375\u5de2<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">CDH1<\/td>\n<td width=\"425\">Breast cancer lobular, Endometrial carcinoma somatic, Gastric cancer hereditary diffuse, Ovarian cancer somatic, Prostate cancer susceptibility<\/td>\n<td width=\"158\">\u80c3<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">CDKN2A<\/td>\n<td width=\"425\">Melanoma and neural system tumor syndrome, Melanoma-pancreatic cancer syndrome, Melanoma,cutaneous malignant 2<\/td>\n<td width=\"158\">\u9ed1\u8272\u7d20, \u80f0\u81df<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">CDK4<\/td>\n<td width=\"425\">Melanoma, cutaneous malignant 3<\/td>\n<td width=\"158\">\u9ed1\u8272\u7d20<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">CHEK2<\/td>\n<td width=\"425\">Breast cancer susceptibility, Li-Fraumeni syndrome, Colorectal and gastric cancer susceptibility, Osteosarcoma somatic, Prostate cancer familial susceptibility<\/td>\n<td width=\"158\">\u4e73\u623f, \u5927\u8178, \u524d\u5217\u817a<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">EPCAM<\/td>\n<td width=\"425\">Colorectal cancer, hereditary nonpolyposis, type 8<\/td>\n<td width=\"158\">\u5375\u5de2, \u5b50\u5bae, \u5927\u8178, \u80f0\u81df, \u80c3<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">GREM1<\/td>\n<td width=\"425\">Colorectal cancer risk association<\/td>\n<td width=\"158\">\u5927\u8178<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">FH<\/td>\n<td width=\"425\">Leiomyomatosis and renal cell cancer<\/td>\n<td width=\"158\">\u814e<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">FLCN<\/td>\n<td width=\"425\">Birt-Hogg-Dube syndrome<\/td>\n<td width=\"158\">\u814e<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">MAX<\/td>\n<td width=\"425\">Pheochromocytoma susceptibility<\/td>\n<td width=\"158\">\u55dc\u927b\u7d30\u80de\u7624<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">MEN1 *<\/td>\n<td width=\"425\">Multiple endocrine neoplasia 1<\/td>\n<td width=\"158\">\u591a\u767c\u6027\u5167\u5206\u6ccc\u816b\u7624<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">MITF<\/td>\n<td width=\"425\">Melanoma susceptibility<\/td>\n<td width=\"158\">\u9ed1\u8272\u7d20<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">MLH1<\/td>\n<td width=\"425\">Colorectal cancer hereditary nonpolyposis type 2, Mismatch repair cancer, Muir-Torre syndrome, Lynch syndrome<\/td>\n<td width=\"158\">\u5375\u5de2, \u5b50\u5bae, \u5927\u8178, \u80f0\u81df, \u80c3<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">MSH2<\/td>\n<td width=\"425\">Colorectal cancer hereditary nonpolyposis type 1, Mismatch repair cancer syndrome, Muir-Torre syndrome, Lynch syndrome<\/td>\n<td width=\"158\">\u5375\u5de2, \u5b50\u5bae, \u5927\u8178, \u80f0\u81df, \u80c3<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">MSH6<\/td>\n<td width=\"425\">Colorectal cancer hereditary nonpolyposis type 5, Endometrial cancer familial, Mismatch repair cancer syndrome, Lynch syndrome<\/td>\n<td width=\"158\">\u5375\u5de2, \u5b50\u5bae, \u5927\u8178, \u80c3, \u524d\u5217\u817a<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">MUTYH<\/td>\n<td width=\"425\">Adenomas multiple colorectal, Colorectal adenomatous polyposis autosomal recessive with pilomatricomas, Gastric cancer somatic, Breast cancer susceptibility, Uterine cancer susceptibility<\/td>\n<td width=\"158\">\u5927\u8178<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">NF1<\/td>\n<td width=\"425\">Leukemia juvenile myelomonocytic, Neurofibromatosis familial spinal, Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome, Watson syndrome, Breast cancer susceptibility, Gastric cancer susceptibility, Pancreatic cancer susceptibility<\/td>\n<td width=\"158\">\u795e\u7d93, \u80ba<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">NBN<\/td>\n<td width=\"425\">Leukemia, acute lymphoblastic, Breast cancer susceptibility<\/td>\n<td width=\"158\">\u4e73\u623f, \u524d\u5217\u817a<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">NF2<\/td>\n<td width=\"425\">Neurofibromatosis, type 2<\/td>\n<td width=\"158\">\u795e\u7d93<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">PALB2<\/td>\n<td width=\"425\">Breast cancer susceptibility, Fanconi anemia complementation group N, Pancreatic cancer susceptibility to 3, Lynch syndrome<\/td>\n<td width=\"158\">\u4e73\u623f, \u5375\u5de2, \u80f0\u81df<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">POLD1<\/td>\n<td width=\"425\">Colorectal cancer, susceptibility to, 10<\/td>\n<td width=\"158\">\u5927\u8178<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">POLE<\/td>\n<td width=\"425\">Colorectal cancer, susceptibility to, 12<\/td>\n<td width=\"158\">\u5927\u8178<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">PMS2<\/td>\n<td width=\"425\">Colorectal cancer hereditary nonpolyposis type 4, Mismatch repair cancer syndrome, Pancreatic cancer susceptibility<\/td>\n<td width=\"158\">\u5375\u5de2, \u5b50\u5bae, \u5927\u8178, \u80c3<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">PTEN<\/td>\n<td width=\"425\">Cowden syndrome Glioma susceptibility 2, Lhermitte-Duclos syndrome, Meningioma, Prostate cancer somatic, Breast cancer susceptibility<\/td>\n<td width=\"158\">\u4e73\u623f, \u5b50\u5bae, \u5927\u8178, \u9ed1\u8272\u7d20<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">RAD50<\/td>\n<td width=\"425\">Breast cancer susceptibility, Ovarian cancer susceptibility, Nijmegen breakage syndrome-like disorder<\/td>\n<td width=\"158\">\u4e73\u623f,\u00a0 \u5375\u5de2<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">RAD51C<\/td>\n<td width=\"425\">Breast-ovarian cancer familial susceptibility, Fanconi anemia complementation group O<\/td>\n<td width=\"158\">\u5375\u5de2<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">RAD51D<\/td>\n<td width=\"425\">Breast-ovarian cancer familial susceptibility to 4<\/td>\n<td width=\"158\">\u5375\u5de2<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">RB1<\/td>\n<td width=\"425\">Retinoblastoma<\/td>\n<td width=\"158\">\u8996\u7db2\u819c, \u8180\u80f1, \u80ba, \u9aa8<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">RET<\/td>\n<td width=\"425\">Multiple endocrine neoplasia IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma; Hirschsprung disease, susceptibility to<\/td>\n<td width=\"158\">\u5167\u5206\u6ccc, \u7532\u72c0\u817a, \u80ba<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">SDHAF2<\/td>\n<td width=\"425\">Paragangliomas 2<\/td>\n<td width=\"158\">\u526f\u795e\u7d93\u7bc0\u7624<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">SDHA<\/td>\n<td width=\"425\">Paragangliomas 5, Gastric cancer susceptibility<\/td>\n<td width=\"158\">\u526f\u795e\u7d93\u7bc0\u7624, \u80c3<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">SDHB<\/td>\n<td width=\"425\">Gastrointestinal stromal tumor, Paraganglioma and gastric stromal sarcoma, Paragangliomas 4, Pheochromocytoma<\/td>\n<td width=\"158\">\u80c3\u8178\u9053, \u795e\u7d93, \u52d5\u8108<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">SDHC<\/td>\n<td width=\"425\">Gastrointestinal stromal tumor, Paraganglioma and gastric stromal sarcoma, Paragangliomas 3<\/td>\n<td width=\"158\">\u80c3\u8178\u9053, \u795e\u7d93<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">SDHD<\/td>\n<td width=\"425\">Paraganglioma and gastric stromal sarcoma, Paragangliomas 1, Pheochromocytoma<\/td>\n<td width=\"158\">\u80c3\u8178\u9053, \u795e\u7d93, \u55dc\u927b\u7d30\u80de\u7624<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">SMAD4<\/td>\n<td width=\"425\">Juvenile polyposis\/hereditary hemorrhagic telangiectasia syndrome, Pancreatic cancer somatic,Polyposis juvenile intestinal<\/td>\n<td width=\"158\">\u5927\u8178, \u80f0\u81df, \u80c3<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">STK11<\/td>\n<td width=\"425\">Pancreatic cancer somatic, Peutz-Jeghers syndrome, Testicular tumor somatic, Colorectal cancer susceptibility, Gastric cancer susceptibility, Breast cancer susceptibility<\/td>\n<td width=\"158\">\u4e73\u623f, \u5375\u5de2, \u5b50\u5bae, \u5927\u8178, \u80f0\u81df, \u80c3<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">TMEM127<\/td>\n<td width=\"425\">Pheochromocytoma<\/td>\n<td width=\"158\">\u55dc\u927b\u7d30\u80de\u7624<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">TSC1<\/td>\n<td width=\"425\">Tuberous sclerosis-1<\/td>\n<td width=\"158\">\u7d50\u7bc0\u6027\u786c\u5316\u75c7, \u8180\u80f1<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">TSC2<\/td>\n<td width=\"425\">Tuberous sclerosis-2, Pancreatic cancer<\/td>\n<td width=\"158\">\u7d50\u7bc0\u6027\u786c\u5316\u75c7, \u80f0\u81df<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">TP53<\/td>\n<td width=\"425\">Adrenocortical carcinoma pediatric, Basal cell carcinoma 7, Bone marrow failure syndrome, Breast cancer somatic, Choroid plexus papilloma, Colorectal cancer, Glioma susceptibility 1, Hepatocellular carcinoma somatic, Li-Fraumeni syndrome, Nasopharyngeal carcinoma somatic, Osteosarcoma, Pancreatic cancer somatic<\/td>\n<td width=\"158\">\u5168\u90e8\u764c\u75c7\u7686\u6709\u76f8\u95dc<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">VHL<\/td>\n<td width=\"425\">Pheochromocytoma, Renal cell carcinoma somatic, von Hippel-Lindau syndrome<\/td>\n<td width=\"158\">\u55dc\u927b\u7d30\u80de\u7624, \u814e\u7d30\u80de, \u8840\u7ba1\u7624<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">WT1<\/td>\n<td width=\"425\">Wilms tumor, type 1<\/td>\n<td width=\"158\">\u814e<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<style type=\"text\/css\"><\/style><div class=\"fusion-title title fusion-title-2 fusion-sep-none fusion-title-text fusion-title-size-one\" style=\"margin-top:0px;margin-right:0px;margin-bottom:0px;margin-left:0px;\"><h1 class=\"title-heading-left fusion-responsive-typography-calculated\" style=\"margin:0;--fontSize:80;line-height:1;\"><h2><\/h2>\n<h2 style=\"text-align: center;\">\u5fc3\u8840\u7ba1\u75be\u75c5<\/h2>\n<h2><\/h2><\/h1><\/div>\n<div class=\"table-1\">\n<table style=\"height: 12057px;\" width=\"1068\">\n<tbody>\n<tr>\n<td width=\"92\">\u57fa\u56e0\u540d<\/td>\n<td width=\"388\">\u76f8\u95dc\u75be\u75c5<\/td>\n<td width=\"201\">\u75be\u75c5\u4e2d\u6587\u540d<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">A2ML1<\/td>\n<td width=\"388\">Noonan Syndrome 1<\/td>\n<td width=\"201\">\u52aa\u5357\u6c0f\u75c7\u5019\u7fa4<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">ABCC9<\/td>\n<td width=\"388\">Atrial fibrillation, familial 12, Cardiomyopathy dilated 10, Hypertrichotic osteochondrodysplasia<\/td>\n<td width=\"201\">\u5fc3\u623f\u986b\u52d5<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">ABCG5<\/td>\n<td width=\"388\">Hypercholesterolaemia, Sitosterolemia 2<\/td>\n<td width=\"201\">\u5bb6\u65cf\u6027\u9ad8\u81bd\u56fa\u9187<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">ABCG8<\/td>\n<td width=\"388\">Hypercholesterolaemia, Sitosterolemia 1<\/td>\n<td width=\"201\">\u5bb6\u65cf\u6027\u9ad8\u81bd\u56fa\u9187<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">ACADVL<\/td>\n<td width=\"388\">VLCAD deficiency<\/td>\n<td width=\"201\">VLCAD\u7f3a\u4e4f\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">ACTC1<\/td>\n<td width=\"388\">Atrial septal defect 5, Cardiomyopathy dilated 1R, Cardiomyopathy hypertrophic 11, Left ventricular noncompaction 4<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">ACTN2<\/td>\n<td width=\"388\">Cardiomyopathy dilated 1AA with or without LVNC, Cardiomyopathy hypertrophic 23 with or without LVNC<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">AGL<\/td>\n<td width=\"388\">Glycogen storage disease IIIa, Glycogen storage disease IIIb<\/td>\n<td width=\"201\">\u809d\u91a3\u5132\u7a4d\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">AKAP9<\/td>\n<td width=\"388\">Long QT syndrome-11<\/td>\n<td width=\"201\">\u5fc3\u5f8b\u4e0d\u6574<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">ALG10B<\/td>\n<td width=\"388\">\u00a0Reduced susceptibility to acquired Long QT syndrome<\/td>\n<td width=\"201\">\u5fc3\u5f8b\u4e0d\u6574<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">ALMS1<\/td>\n<td width=\"388\">Alstrom syndrome<\/td>\n<td width=\"201\">ALSTROM\u6c0f\u75c7\u5019\u7fa4<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">ANK2<\/td>\n<td width=\"388\">Cardiac arrhythmia ankyrin-B-related, Long QT syndrome 4<\/td>\n<td width=\"201\">\u5fc3\u5f8b\u4e0d\u6574<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">ANKRD1<\/td>\n<td width=\"388\">Familial dilated cardiomyopathy<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">APOB<\/td>\n<td width=\"388\">Hypercholesterolemia familial 2,Hypobetalipoproteinemia<\/td>\n<td width=\"201\">\u5bb6\u65cf\u6027\u9ad8\u81bd\u56fa\u9187<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">BAG3<\/td>\n<td width=\"388\">Cardiomyopathy dilated 1HH, Myopathy myofibrillar 6<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">BRAF<\/td>\n<td width=\"388\">Cardiofaciocutaneous syndrome, LEOPARD syndrome 3, Noonan syndrome 7<\/td>\n<td width=\"201\">\u52aa\u5357\u6c0f\u75c7\u5019\u7fa4<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">CACNA1C<\/td>\n<td width=\"388\">Brugada syndrome 3, Long QT syndrome 8, Timothy syndrome<\/td>\n<td width=\"201\">\u5fc3\u5f8b\u4e0d\u6574<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">CACNA2D1<\/td>\n<td width=\"388\">Brugada syndrome<\/td>\n<td width=\"201\">\u5fc3\u5f8b\u4e0d\u6574<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">CACNB2<\/td>\n<td width=\"388\">Brugada syndrome 4<\/td>\n<td width=\"201\">\u5fc3\u5f8b\u4e0d\u6574<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">CALM1<\/td>\n<td width=\"388\">Long QT syndrome 14, Ventricular tachycardia catecholaminergic polymorphic 4<\/td>\n<td width=\"201\">\u5fc3\u5f8b\u4e0d\u6574<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">CALM2<\/td>\n<td width=\"388\">Long QT syndrome 15<\/td>\n<td width=\"201\">\u5fc3\u5f8b\u4e0d\u6574<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">CALM3<\/td>\n<td width=\"388\">Long Qt Syndrome 1, Catecholaminergic Polymorphic Ventricular Tachycardia<\/td>\n<td width=\"201\">\u5fc3\u5f8b\u4e0d\u6574<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">CALR3<\/td>\n<td width=\"388\">Familial hypertrophic cardiomyopathy (?)<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">CASQ2<\/td>\n<td width=\"388\">Ventricular tachycardia catecholaminergic polymorphic 2<\/td>\n<td width=\"201\">\u5fc3\u5f8b\u4e0d\u6574<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">CAV3<\/td>\n<td width=\"388\">Cardiomyopathy familial hypertrophic, Creatine phosphokinase elevated serum, Long QT syndrome 9, Myopathy distal Tateyama type, Rippling muscle disease 2<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a\u3001\u5fc3\u5f8b\u4e0d\u6574<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">CBL<\/td>\n<td width=\"388\">Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia<\/td>\n<td width=\"201\">\u985e\u52aa\u5357\u6c0f\u75c7\u5019\u7fa4<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">CHRM2<\/td>\n<td width=\"388\">Familial dilated cardiomyopathy<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">CPT2<\/td>\n<td width=\"388\">CPT II deficiency infantile, CPT II deficiency lethal neonatal, CPT II deficiency myopathic stress-induced<\/td>\n<td width=\"201\">CPT2\u7f3a\u4e4f\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">CRYAB<\/td>\n<td width=\"388\">Cardiomyopathy dilated 1II, Myopathy myofibrillar 2, Myopathy myofibrillar fatal infantile hypertonic alpha-B crystallin-related<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">CSRP3<\/td>\n<td width=\"388\">Cardiomyopathy dilated 1M, Cardiomyopathy hypertrophic 12<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">CTF1<\/td>\n<td width=\"388\">Neonatal Stroke, Hypertensive Heart Disease<\/td>\n<td width=\"201\">\u65b0\u751f\u5152\u731d\u6b7b\u3001\u9ad8\u8840\u58d3<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">CTNNA3<\/td>\n<td width=\"388\">Arrhythmogenic right ventricular dysplasia familial 13<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">DES<\/td>\n<td width=\"388\">Cardiomyopathy dilated 1I, Myopathy myofibrillar 1, Scapuloperoneal syndrome neurogenic Kaeser type<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">DMD<\/td>\n<td width=\"388\">Becker muscular dystrophy, Cardiomyopathy dilated 3B, Duchenne muscular dystrophy<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">DNAJC19<\/td>\n<td width=\"388\">3-methylglutaconic aciduria type V<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">DOLK<\/td>\n<td width=\"388\">Congenital disorder of glycosylation type Im<\/td>\n<td width=\"201\">\u5148\u5929\u6027\u7cd6\u57fa\u5316\u969c\u7919<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">DSC2<\/td>\n<td width=\"388\">Arrhythmogenic right ventricular dysplasia 11, Arrhythmogenic right ventricular dysplasia 11 with mild palmoplantar keratoderma and woolly hair<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">DSG2<\/td>\n<td width=\"388\">Arrhythmogenic right ventricular dysplasia 10, Cardiomyopathy dilated 1BB<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">DSP<\/td>\n<td width=\"388\">Arrhythmogenic right ventricular dysplasia 8, Cardiomyopathy dilated with woolly hair and keratoderma,<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">DTNA<\/td>\n<td width=\"388\">Left ventricular noncompaction 1 with or without congenital heart defects<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">ELAC2<\/td>\n<td width=\"388\">Combined oxidative phosphorylation deficiency 17<\/td>\n<td width=\"201\">\uf9f9\u7dda\u9ad4\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">EMD<\/td>\n<td width=\"388\">Emery-Dreifuss muscular dystrophy 1 X-linked<\/td>\n<td width=\"201\">\u808c\u8089\u5931\u990a\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">EYA4<\/td>\n<td width=\"388\">Cardiomyopathy dilated 1J , Deafness autosomal dominant 10<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">FGF12<\/td>\n<td width=\"388\">Brugada syndrome, Epileptic encephalopathy early infantile 47<\/td>\n<td width=\"201\">\u5fc3\u5f8b\u4e0d\u6574<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">FHL1<\/td>\n<td width=\"388\">Emery-Dreifuss muscular dystrophy 6 X-linked, Myopathy X-linked with postural muscle atrophy, Reducing body myopathy X-linked, Uruguay faciocardiomusculoskeletal syndrome<\/td>\n<td width=\"201\">\u808c\u8089\u5931\u990a\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">FHL2<\/td>\n<td width=\"388\">Familial dilated cardiomyopathy<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">FKRP<\/td>\n<td width=\"388\">Muscular dystrophy-dystroglycanopathy<\/td>\n<td width=\"201\">\u808c\u5931\u990a\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">FKTN<\/td>\n<td width=\"388\">Cardiomyopathy dilated 1, Muscular dystrophy-dystroglycanopathy<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">FLNC<\/td>\n<td width=\"388\">Cardiomyopathy familial restrictive 5, Myopathy distal 4, Myopathy myofibrillar 5<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">GAA<\/td>\n<td width=\"388\">Glycogen storage disease II<\/td>\n<td width=\"201\">\u9f90\u8c9d\u6c0f\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">GATA4<\/td>\n<td width=\"388\">Atrial septal defect, Tetralogy of Fallot, Ventricular septal defect 1<\/td>\n<td width=\"201\">\u5fc3\u5f8b\u4e0d\u6574, \u5fc3\u623f\u4e2d\u8188\u7f3a\u640d<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">GATA6<\/td>\n<td width=\"388\">Atrial septal defect 9, Atrioventricular septal defect 5, Pancreatic agenesis and congenital heart defects, Persistent truncus arteriosus, Tetralogy of Fallot<\/td>\n<td width=\"201\">\u5fc3\u5f8b\u4e0d\u6574, \u5fc3\u623f\u4e2d\u8188\u7f3a\u640d<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">GATAD1<\/td>\n<td width=\"388\">Cardiomyopathy dilated 2B<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">GLA<\/td>\n<td width=\"388\">Fabry disease, Fabry disease cardiac variant<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">GPD1L<\/td>\n<td width=\"388\">Brugada syndrome 2<\/td>\n<td width=\"201\">\u5fc3\u5f8b\u4e0d\u6574<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">HCN4<\/td>\n<td width=\"388\">Brugada syndrome 8, Sick sinus syndrome 2<\/td>\n<td width=\"201\">\u5fc3\u5f8b\u4e0d\u6574, \u75c5\u7ac7\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">HRAS<\/td>\n<td width=\"388\">Congenital myopathy with excess of muscle spindles, Costello syndrome,<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">ILK<\/td>\n<td width=\"388\">Cardiomyopathy dilated, Cardiomyopathy hypertrophic<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">JPH2<\/td>\n<td width=\"388\">Cardiomyopathy hypertrophic 17<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">JUP<\/td>\n<td width=\"388\">Arrhythmogenic right ventricular dysplasia 12, Naxos disease<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">KCND2<\/td>\n<td width=\"388\">Atrial fibrillation<\/td>\n<td width=\"201\">\u5fc3\u623f\u986b\u52d5<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">KCND3<\/td>\n<td width=\"388\">Brugada syndrome 9, Spinocerebellar ataxia 19<\/td>\n<td width=\"201\">\u5fc3\u5f8b\u4e0d\u6574<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">KCNE1<\/td>\n<td width=\"388\">Jervell and Lange-Nielsen syndrome 2, Long QT syndrome 5<\/td>\n<td width=\"201\">\u5fc3\u5f8b\u4e0d\u6574<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">KCNE2<\/td>\n<td width=\"388\">Atrial fibrillation familial 4 , Long QT syndrome 6<\/td>\n<td width=\"201\">\u5fc3\u5f8b\u4e0d\u6574<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">KCNE3<\/td>\n<td width=\"388\">Brugada syndrome 6<\/td>\n<td width=\"201\">\u5fc3\u5f8b\u4e0d\u6574<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">KCNE5<\/td>\n<td width=\"388\">Brugada syndrome<\/td>\n<td width=\"201\">\u5fc3\u5f8b\u4e0d\u6574<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">KCNH2<\/td>\n<td width=\"388\">Long QT syndrome 2, acquired susceptibility to Long QT syndrome 2, Short QT syndrome 1<\/td>\n<td width=\"201\">\u5fc3\u5f8b\u4e0d\u6574<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">KCNJ2<\/td>\n<td width=\"388\">Andersen syndrome, Atrial fibrillation familial 9, Short QT syndrome 3<\/td>\n<td width=\"201\">\u5fc3\u5f8b\u4e0d\u6574, Andersen \u6c0f\u75c7\u5019\u7fa4<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">KCNJ5<\/td>\n<td width=\"388\">Hyperaldosteronism familial type III, Long QT syndrome 13<\/td>\n<td width=\"201\">\u5fc3\u5f8b\u4e0d\u6574<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">KCNJ8<\/td>\n<td width=\"388\">Brugada syndrome<\/td>\n<td width=\"201\">\u5fc3\u5f8b\u4e0d\u6574<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">KCNQ1<\/td>\n<td width=\"388\">Atrial fibrillation familial 3, Jervell and Lange- Nielsen syndrome, Long QT syndrome 1, Short QT syndrome 2<\/td>\n<td width=\"201\">\u5fc3\u623f\u986b\u52d5<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">KRAS<\/td>\n<td width=\"388\">Cardiofaciocutaneous syndrome 2, Noonan syndrome 3, Oculoectodermal syndrome<\/td>\n<td width=\"201\">\u52aa\u5357\u6c0f\u75c7\u5019\u7fa4<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">LAMA4<\/td>\n<td width=\"388\">Cardiomyopathy dilated 1JJ<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">LAMP2<\/td>\n<td width=\"388\">Danon disease<\/td>\n<td width=\"201\">\u808c\u8089\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">LDB3<\/td>\n<td width=\"388\">Cardiomyopathy dilated 1C with or without LVNC, Cardiomyopathy hypertrophic 24, Left ventricular noncompaction 3, Myopathy myofibrillar 4<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">LDLR<\/td>\n<td width=\"388\">Hypercholesterolemia familial 1<\/td>\n<td width=\"201\">\u5bb6\u65cf\u6027\u9ad8\u81bd\u56fa\u9187<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">LDLRAP1<\/td>\n<td width=\"388\">Hypercholesterolemia, familial, 4<\/td>\n<td width=\"201\">\u5bb6\u65cf\u6027\u9ad8\u81bd\u56fa\u9187<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">LMNA<\/td>\n<td width=\"388\">Cardiomyopathy dilated 1A, Charcot-Marie-Tooth disease type 2B1, Emery-Dreifuss muscular congenital dystrophy, Heart-hand syndrome Slovenian type, Hutchinson-Gilford progeria, Lipodystrophy familial partial type 2, Malouf syndrome, Muscular dystrophy congenital<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">LRRC10<\/td>\n<td width=\"388\">Dilated Cardiomyopathy<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">MAP2K1<\/td>\n<td width=\"388\">Cardiofaciocutaneous syndrome 3<\/td>\n<td width=\"201\">\u5fc3\u81df\u9762\u90e8\u76ae\u819a\u7d9c\u5408\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">MAP2K2<\/td>\n<td width=\"388\">Cardiofaciocutaneous syndrome 4<\/td>\n<td width=\"201\">\u5fc3\u81df\u9762\u90e8\u76ae\u819a\u7d9c\u5408\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">MTO1<\/td>\n<td width=\"388\">Combined oxidative phosphorylation deficiency 10<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">MYBPC3<\/td>\n<td width=\"388\">Cardiomyopathy dilated 1MM, Cardiomyopathy hypertrophic 4, Left ventricular noncompaction 10<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">MYH6<\/td>\n<td width=\"388\">Atrial septal defect 3, Cardiomyopathy dilated 1EE, Cardiomyopathy hypertrophic 14, Sick sinus syndrome 3<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">MYH7<\/td>\n<td width=\"388\">Cardiomyopathy dilated 1S, Cardiomyopathy hypertrophic 1, Laing distal myopathy, Left ventricular noncompaction 5, Myopathy myosinstorage<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">MYL2<\/td>\n<td width=\"388\">Cardiomyopathy hypertrophic 10<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">MYL3<\/td>\n<td width=\"388\">Cardiomyopathy hypertrophic 8<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">MYLK2<\/td>\n<td width=\"388\">Cardiomyopathy hypertrophic 1 digenic<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">MYOM1<\/td>\n<td width=\"388\">Cardiomyopathy hypertrophic<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">MYOZ2<\/td>\n<td width=\"388\">Cardiomyopathy hypertrophic 16<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">MYPN<\/td>\n<td width=\"388\">Cardiomyopathy dilated 1KK, Cardiomyopathy familial restrictive 4, Cardiomyopathy hypertrophic 22, Nemaline myopathy 11 autosomal recessive<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">NEBL<\/td>\n<td width=\"388\">Endocardial Fibroelastosis<\/td>\n<td width=\"201\">\u5fc3\u5167\u819c\u7e96\u7dad\u5316<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">NEXN<\/td>\n<td width=\"388\">Cardiomyopathy dilated 1CC, Cardiomyopathy hypertrophic 20<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">NF1<\/td>\n<td width=\"388\">Neurofibromatosis-Noonan syndrome<\/td>\n<td width=\"201\">\u52aa\u5357\u6c0f\u75c7\u5019\u7fa4<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">NKX2-5<\/td>\n<td width=\"388\">Atrial septal defect 7 with or without AV conduction defects, Conotruncal heart malformations variable, Hypoplastic left heart syndrome 2, Tetralogy of Fallot, Ventricular septal defect 3<\/td>\n<td width=\"201\">\u5fc3\u5f8b\u4e0d\u6574, \u5fc3\u623f\u4e2d\u8188\u7f3a\u640d<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">NPPA<\/td>\n<td width=\"388\">Atrial fibrillation familial 6, Atrial standstill 2<\/td>\n<td width=\"201\">\u5fc3\u623f\u986b\u52d5<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">NRAS<\/td>\n<td width=\"388\">Noonan syndrome 6<\/td>\n<td width=\"201\">\u52aa\u5357\u6c0f\u75c7\u5019\u7fa4<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">PCSK9<\/td>\n<td width=\"388\">Hypercholesterolemia familial 3<\/td>\n<td width=\"201\">\u5bb6\u65cf\u6027\u9ad8\u81bd\u56fa\u9187<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">PDLIM3<\/td>\n<td width=\"388\">Cardiomyopathy hypertrophic, Cardiomyopathy, dilated<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">PKP2<\/td>\n<td width=\"388\">Arrhythmogenic right ventricular dysplasia 9<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">PLEKHM2<\/td>\n<td width=\"388\">Left Ventricular Noncompaction, Dilated Cardiomyopathy<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">PLN<\/td>\n<td width=\"388\">Cardiomyopathy dilated 1P, Cardiomyopathy hypertrophic 18<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">PRDM16<\/td>\n<td width=\"388\">Cardiomyopathy dilated 1LL, Left ventricular noncompaction 8<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">PRKAG2<\/td>\n<td width=\"388\">Cardiomyopathy hypertrophic 6, Glycogen storage disease of heart lethal congenital, Wolff-Parkinson- White syndrome<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">PTPN11<\/td>\n<td width=\"388\">LEOPARD syndrome 1, Noonan syndrome 1<\/td>\n<td width=\"201\">\u52aa\u5357\u6c0f\u75c7\u5019\u7fa4<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">RAF1<\/td>\n<td width=\"388\">Cardiomyopathy dilated 1NN, LEOPARD syndrome 2, Noonan syndrome 5<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a, \u52aa\u5357\u6c0f\u75c7\u5019\u7fa4<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">RANGRF<\/td>\n<td width=\"388\">Brugada syndrome<\/td>\n<td width=\"201\">\u5fc3\u5f8b\u4e0d\u6574<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">RASA1<\/td>\n<td width=\"388\">Capillary malformation-arteriovenous malformation 1<\/td>\n<td width=\"201\">\u6bdb\u7d30\u8840\u7ba1\u52d5\u975c\u8108\u7578\u5f62<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">RBM20<\/td>\n<td width=\"388\">Cardiomyopathy dilated 1DD<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">RIT1<\/td>\n<td width=\"388\">Noonan syndrome 8<\/td>\n<td width=\"201\">\u52aa\u5357\u6c0f\u75c7\u5019\u7fa4<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">RRAS<\/td>\n<td width=\"388\">Noonan syndrome<\/td>\n<td width=\"201\">\u52aa\u5357\u6c0f\u75c7\u5019\u7fa4<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">RYR2<\/td>\n<td width=\"388\">Arrhythmogenic right ventricular dysplasia 2, Ventricular tachycardia catecholaminergic polymorphic 1<\/td>\n<td width=\"201\">\u5fc3\u5f8b\u4e0d\u6574<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">SCN10A<\/td>\n<td width=\"388\">Heart block, Episodic pain syndrome familial 2<\/td>\n<td width=\"201\">\u5fc3\u5f8b\u4e0d\u6574<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">SCN1B<\/td>\n<td width=\"388\">Atrial fibrillation familial 13, Brugada syndrome 5, Cardiac conduction defect nonspecific<\/td>\n<td width=\"201\">\u5fc3\u623f\u986b\u52d5<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">SCN2B<\/td>\n<td width=\"388\">Atrial fibrillation familial 14<\/td>\n<td width=\"201\">\u5fc3\u623f\u986b\u52d5<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">SCN3B<\/td>\n<td width=\"388\">Atrial fibrillation familial 16, Brugada syndrome 7<\/td>\n<td width=\"201\">\u5fc3\u623f\u986b\u52d5<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">SCN4B<\/td>\n<td width=\"388\">Atrial fibrillation familial 17, Long QT syndrome-10<\/td>\n<td width=\"201\">\u5fc3\u623f\u986b\u52d5<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">SCN5A<\/td>\n<td width=\"388\">Atrial fibrillation familial 10, Brugada syndrome 1, Cardiomyopathy dilated 1E, Heart block, Long QT syndrome-3, Sick sinus syndrome 1, Susceptibility to Sudden infant death syndrome, Ventricular fibrillation familial 1<\/td>\n<td width=\"201\">\u5fc3\u5f8b\u4e0d\u6574<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">SDHA<\/td>\n<td width=\"388\">Cardiomyopathy dilated 1GG, Leigh syndrome, Mitochondrial respiratory chain complex II deficiency<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">SEMA3A<\/td>\n<td width=\"388\">Brugada syndrome<\/td>\n<td width=\"201\">\u5fc3\u5f8b\u4e0d\u6574<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">SGCD<\/td>\n<td width=\"388\">Cardiomyopathy dilated 1L, Muscular dystrophy limb- girdle autosomal recessive 6<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">SHOC2<\/td>\n<td width=\"388\">Noonan syndrome-like with loose anagen hair<\/td>\n<td width=\"201\">\u52aa\u5357\u6c0f\u75c7\u5019\u7fa4<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">SLC22A5<\/td>\n<td width=\"388\">Carnitine deficiency systemic primary<\/td>\n<td width=\"201\">\u539f\u767c\u6027\u8089\u9e7c\u7f3a\u4e4f\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">SLMAP<\/td>\n<td width=\"388\">Brugada syndrome<\/td>\n<td width=\"201\">\u5fc3\u5f8b\u4e0d\u6574<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">SNTA1<\/td>\n<td width=\"388\">Long QT syndrome 12<\/td>\n<td width=\"201\">\u5fc3\u5f8b\u4e0d\u6574<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">SOS1<\/td>\n<td width=\"388\">Noonan syndrome 4<\/td>\n<td width=\"201\">\u52aa\u5357\u6c0f\u75c7\u5019\u7fa4<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">SOS2<\/td>\n<td width=\"388\">Noonan syndrome 9<\/td>\n<td width=\"201\">\u52aa\u5357\u6c0f\u75c7\u5019\u7fa4<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">SPRED1<\/td>\n<td width=\"388\">Legius syndrome<\/td>\n<td width=\"201\">\u96f7\u5409\u58eb\u75c7\u5019\u7fa4<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">TAZ<\/td>\n<td width=\"388\">Barth syndrome<\/td>\n<td width=\"201\">\u5df4\u6c0f\u75c7\u5019\u7fa4<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">TBX20<\/td>\n<td width=\"388\">Atrial septal defect 4, Cardiomyopathy hypertrophic, Cardiomyopathy dilated, LV Noncompaction<\/td>\n<td width=\"201\">\u5fc3\u5f8b\u4e0d\u6574, \u5fc3\u623f\u4e2d\u8188\u7f3a\u640d<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">TCAP<\/td>\n<td width=\"388\">Cardiomyopathy hypertrophic 25, Muscular dystrophy limb-girdle autosomal recessive 7<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">TGFB3<\/td>\n<td width=\"388\">Arrhythmogenic right ventricular dysplasia 1, Loeys-Dietz syndrome 5<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">TMEM43<\/td>\n<td width=\"388\">Arrhythmogenic right ventricular dysplasia 5, Emery- Dreifuss muscular dystrophy 7<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">TMEM70<\/td>\n<td width=\"388\">Mitochondrial complex V (ATP synthase) deficiency nuclear type 2<\/td>\n<td width=\"201\">\u7c92\u7dda\u9ad4\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">TMPO<\/td>\n<td width=\"388\">Dilated Cardiomyopathy<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">TNNC1<\/td>\n<td width=\"388\">Cardiomyopathy dilated 1Z, Cardiomyopathy hypertrophic 13<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a, \u5fc3\u5f8b\u4e0d\u6574<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">TNNI3<\/td>\n<td width=\"388\">Cardiomyopathy dilated 1FF, Cardiomyopathy dilated 2A, Cardiomyopathy familial restrictive 1, Cardiomyopathy hypertrophic 7<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">TNNT2<\/td>\n<td width=\"388\">Cardiomyopathy dilated 1D, Cardiomyopathy familial restrictive 3, Cardiomyopathy hypertrophic 2,\u00a0 Left ventricular noncompaction 6<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">TPM1<\/td>\n<td width=\"388\">Cardiomyopathy dilated 1Y, Cardiomyopathy hypertrophic 3, Left ventricular noncompaction 9<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">TRDN<\/td>\n<td width=\"388\">Ventricular tachycardia catecholaminergic polymorphic 5<\/td>\n<td width=\"201\">\u5fc3\u5f8b\u4e0d\u6574<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">TRPM4<\/td>\n<td width=\"388\">Progressive familial heart block type IB<\/td>\n<td width=\"201\">\u5fc3\u5f8b\u4e0d\u6574<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">TTN<\/td>\n<td width=\"388\">Cardiomyopathy dilated 1G, Cardiomyopathy familial hypertrophic 9, Muscular dystrophy limb-girdle autosomal recessive 10, Salih myopathy<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">TTR<\/td>\n<td width=\"388\">Amyloidosis hereditary transthyretin-related<\/td>\n<td width=\"201\">\u985e\u6fb1\u7c89\u591a\u767c\u6027\u795e\u7d93\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">TXNRD2<\/td>\n<td width=\"388\">Glucocorticoid deficiency 5, dilated cardiomyopathy<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"92\">VCL<\/td>\n<td width=\"388\">Cardiomyopathy dilated 1W, Cardiomyopathy hypertrophic 15<\/td>\n<td width=\"201\">\u5fc3\u808c\u75c5\u8b8a<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<style type=\"text\/css\"><\/style><div class=\"fusion-title title fusion-title-3 fusion-sep-none fusion-title-text fusion-title-size-one\" style=\"margin-top:0px;margin-right:0px;margin-bottom:0px;margin-left:0px;\"><h1 class=\"title-heading-left fusion-responsive-typography-calculated\" style=\"margin:0;--fontSize:80;line-height:1;\"><h2><\/h2>\n<h2 style=\"text-align: center;\">\u7d50\u7de0\u7d44\u7e54<\/h2>\n<h2><\/h2><\/h1><\/div>\n<div class=\"table-1\">\n<table style=\"height: 4489px;\" width=\"1099\">\n<tbody>\n<tr>\n<td width=\"78\">\u57fa\u56e0\u540d<\/td>\n<td width=\"426\">\u76f8\u95dc\u75be\u75c5<\/td>\n<td width=\"167\">\u75be\u75c5\u4e2d\u6587\u540d<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">ABL1<\/td>\n<td width=\"426\">Congenital heart defects and skeletal malformations syndrome<\/td>\n<td width=\"167\">\u5148\u5929\u6027\u5fc3\u81df\u75c5<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">ACTA2<\/td>\n<td width=\"426\">Aortic aneurysm familial thoracic 6, Moyamoya disease 5, Multisystemic smooth muscle dysfunction syndrome<\/td>\n<td width=\"167\">\u52d5\u8108\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">ADAMTS2<\/td>\n<td width=\"426\">Ehlers-Danlos syndrome dermatosparaxis type<\/td>\n<td width=\"167\">\u9b06\u76ae\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">ALDH18A1<\/td>\n<td width=\"426\">Cutis laxa, Spastic paraplegia<\/td>\n<td width=\"167\">\u76ae\u819a\u9b06\u5f1b\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">ATP6V0A2<\/td>\n<td width=\"426\">Cutis laxa, Wrinkly skin syndrome<\/td>\n<td width=\"167\">\u76ae\u819a\u9b06\u99b3\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">ATP7A<\/td>\n<td width=\"426\">Menkes disease, Occipital horn syndrome, Spinal muscular atrophy distal X-linked 3<\/td>\n<td width=\"167\">\u76ae\u819a\u9b06\u99b3\u75c7\u3001Menkes\u75c7\u5019\u7fa4<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">B3GALT6<\/td>\n<td width=\"426\">Ehlers-Danlos syndrome spondylodysplastic type 2, Spondyloepimetaphyseal dysplasia<\/td>\n<td width=\"167\">\u9b06\u76ae\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">B4GALT7<\/td>\n<td width=\"426\">Ehlers-Danlos syndrome spondylodysplastic type 1<\/td>\n<td width=\"167\">\u9b06\u76ae\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">CBS<\/td>\n<td width=\"426\">Homocystinuria B6-responsive and nonresponsive types, Thrombosis hyperhomocysteinemic<\/td>\n<td width=\"167\">\u9ad8\u80f1\u80fa\u9178\u8840\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">CHST14<\/td>\n<td width=\"426\">Ehlers-Danlos syndrome musculocontractural type 1<\/td>\n<td width=\"167\">\u9b06\u76ae\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">COL11A1<\/td>\n<td width=\"426\">Fibrochondrogenesis 1, Deafness autosomal dominant 37, Marshall syndrome, Stickler syndrome type II<\/td>\n<td width=\"167\">\u7e96\u7dad\u8edf\u9aa8\u589e\u751f\u53ca\u8033\u807e<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">COL11A2<\/td>\n<td width=\"426\">Fibrochondrogenesis 2, Deafness, Otospondylomegaepiphyseal dysplasia<\/td>\n<td width=\"167\">\u7e96\u7dad\u8edf\u9aa8\u589e\u751f\u53ca\u8033\u807e<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">COL1A1<\/td>\n<td width=\"426\">Ehlers-Danlos syndrome arthrochalasia type 1, Bone mineral density variation QTL osteoporosis, Caffey disease, Osteogenesis imperfecta<\/td>\n<td width=\"167\">\u9b06\u76ae\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">COL1A2<\/td>\n<td width=\"426\">Ehlers-Danlos syndrome arthrochalasia type 2, Ehlers-Danlos syndrome cardiac valvular type, Osteogenesis imperfecta<\/td>\n<td width=\"167\">\u9b06\u76ae\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">COL2A1<\/td>\n<td width=\"426\">Achondrogenesis type II or hypochondrogenesis, Avascular necrosis of the femoral head, Czech dysplasia, Epiphyseal dysplasia multiple with myopia and deafness, Kniest dysplasia, Legg-Calve-Perthes disease, Osteoarthritis with mild chondrodysplasia, Platyspondylic skeletal dysplasia Torrance type, SED congenita, SMED Strudwick type, Spondyloperipheral dysplasia, Stickler syndrome type I<\/td>\n<td width=\"167\">\u8edf\u9aa8\u751f\u6210\u4e0d\u5168<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">COL3A1<\/td>\n<td width=\"426\">Ehlers-Danlos syndrome vascular type, Polymicrogyria with or without vascular-type EDS<\/td>\n<td width=\"167\">\u52d5\u8108\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">COL5A1<\/td>\n<td width=\"426\">Ehlers-Danlos syndrome classic type 1<\/td>\n<td width=\"167\">\u9b06\u76ae\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">COL5A2<\/td>\n<td width=\"426\">Ehlers-Danlos syndrome classic type 2<\/td>\n<td width=\"167\">\u9b06\u76ae\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">COL9A1<\/td>\n<td width=\"426\">Epiphyseal dysplasia multiple 6, Stickler syndrome type IV<\/td>\n<td width=\"167\">\u65af\u8482\u514b\uf952\u7d9c\u5408\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">COL9A2<\/td>\n<td width=\"426\">Epiphyseal dysplasia multiple 2, Stickler syndrome type V<\/td>\n<td width=\"167\">\u65af\u8482\u514b\uf952\u7d9c\u5408\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">CRTAP<\/td>\n<td width=\"426\">Osteogenesis imperfecta type VII<\/td>\n<td width=\"167\">\u6210\u9aa8\u4e0d\u5168\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">DSE<\/td>\n<td width=\"426\">Ehlers-Danlos syndrome musculocontractural type 2<\/td>\n<td width=\"167\">\u9b06\u76ae\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">EFEMP2<\/td>\n<td width=\"426\">Cutis laxa autosomal recessive type IB<\/td>\n<td width=\"167\">\u76ae\u819a\u9b06\u5f1b\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">ELN<\/td>\n<td width=\"426\">Cutis laxa, Supravalvar aortic stenosis<\/td>\n<td width=\"167\">\u4e3b\u52d5\u8108\u74e3\u819c\u72f9\u7a84<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">FBLN5<\/td>\n<td width=\"426\">Cutis laxa, Macular degeneration age-related 3, Neuropathy hereditary with or without age-related macular degeneration<\/td>\n<td width=\"167\">\u76ae\u819a\u9b06\u5f1b\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">FBN1<\/td>\n<td width=\"426\">Acromicric dysplasia, Ectopia lentis familial, Geleophysic dysplasia 2, MASS syndrome, Marfan lipodystrophy syndrome, Marfan syndrome, Stiff skin syndrome, Weill-Marchesani syndrome 2<\/td>\n<td width=\"167\">\u52d5\u8108\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">FBN2<\/td>\n<td width=\"426\">Contractural arachnodactyly congenital, Macular degeneration early-onset<\/td>\n<td width=\"167\">\u5148\u5929\u6027\u6523\u7e2e\u8718\u86db\u6a23\u6307<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">FKBP14<\/td>\n<td width=\"426\">Ehlers-Danlos syndrome kyphoscoliotic type 2<\/td>\n<td width=\"167\">\u9b06\u76ae\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">FLNA<\/td>\n<td width=\"426\">Cardiac valvular dysplasia X-linked, Congenital short bowel syndrome, FG syndrome 2, Frontometaphyseal dysplasia 1, Heterotopia periventricular 1, Intestinal pseudoobstruction neuronal, Melnick-Needles syndrome, Otopalatodigital syndromeTerminal osseous dysplasia<\/td>\n<td width=\"167\">\u984d\u9aa8\u9aba\u767c\u80b2\u7570\u5e38<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">FOXE3<\/td>\n<td width=\"426\">Susceptibility to aortic aneurysm familial thoracic 11, Cataract 34 multiple types, Anterior segment dysgenesis 2, multiple subtypes<\/td>\n<td width=\"167\">\u80f8\u4e3b\u52d5\u8108\u7624<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">LTBP4<\/td>\n<td width=\"426\">Cutis laxa autosomal recessive type IC<\/td>\n<td width=\"167\">\u76ae\u819a\u9b06\u5f1b\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">MAT2A<\/td>\n<td width=\"426\">Thoracic aortic aneurysms<\/td>\n<td width=\"167\">\u80f8\u4e3b\u52d5\u8108\u7624<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">MED12<\/td>\n<td width=\"426\">Lujan-Fryns syndrome, Ohdo syndrome X-linked, Opitz-Kaveggia syndrome<\/td>\n<td width=\"167\">\u7d50\u8ae6\u53ca\u795e\u7d93\u7d44\u7e54\u767c\u80b2\u7570\u5e38<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">MFAP5<\/td>\n<td width=\"426\">Aortic aneurysm familial thoracic 9<\/td>\n<td width=\"167\">\u4e3b\u52d5\u8108\u7624<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">MYH11<\/td>\n<td width=\"426\">Aortic aneurysm familial thoracic 4<\/td>\n<td width=\"167\">\u52d5\u8108\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">MYLK<\/td>\n<td width=\"426\">Aortic aneurysm familial thoracic 7<\/td>\n<td width=\"167\">\u52d5\u8108\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">NOTCH1<\/td>\n<td width=\"426\">Adams-Oliver syndrome 5, Aortic valve disease 1<\/td>\n<td width=\"167\">\u4e3b\u52d5\u8108\u74e3\u819c\u75be\u75c5<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">P3H1<\/td>\n<td width=\"426\">Osteogenesis imperfecta type VIII<\/td>\n<td width=\"167\">\u6210\u9aa8\u767c\u80b2\u4e0d\u5168\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">PLOD1<\/td>\n<td width=\"426\">Ehlers-Danlos syndrome kyphoscoliotic type 1<\/td>\n<td width=\"167\">\u9b06\u76ae\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">PRDM5<\/td>\n<td width=\"426\">Brittle cornea syndrome 2<\/td>\n<td width=\"167\">\u9b06\u76ae\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">PRKG1<\/td>\n<td width=\"426\">Aortic aneurysm familial thoracic 8<\/td>\n<td width=\"167\">\u52d5\u8108\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">PYCR1<\/td>\n<td width=\"426\">Cutis laxa autosomal recessive type IIB, Cutis laxa autosomal recessive type IIIB<\/td>\n<td width=\"167\">\u76ae\u819a\u9b06\u5f1b\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">RASA1<\/td>\n<td width=\"426\">Basal cell carcinoma somatic, Capillary malformation-arteriovenous malformation 1<\/td>\n<td width=\"167\">\u8840\u7ba1\u7578\u5f62\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">RIN2<\/td>\n<td width=\"426\">Macrocephaly alopecia cutis laxa and scoliosis<\/td>\n<td width=\"167\">\u76ae\u819a\u9b06\u5f1b\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">SKI<\/td>\n<td width=\"426\">Shprintzen-Goldberg syndrome<\/td>\n<td width=\"167\">\u984f\u9762\u53ca\u9aa8\u9abc\u795e\u7d93\u7570\u5e38<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">SLC2A10<\/td>\n<td width=\"426\">Arterial tortuosity syndrome<\/td>\n<td width=\"167\">\u4e3b\u52d5\u8108\u8840\u7ba1\u626d\u66f2<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">SLC39A13<\/td>\n<td width=\"426\">Ehlers-Danlos syndrome spondylodysplastic type 3<\/td>\n<td width=\"167\">\u9b06\u76ae\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">SMAD3<\/td>\n<td width=\"426\">Loeys-Dietz syndrome 3<\/td>\n<td width=\"167\">\u52d5\u8108\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">SMAD4<\/td>\n<td width=\"426\">Juvenile polyposis\/hereditary hemorrhagic telangiectasia syndrome, Myhre syndrome, Pancreatic cancer somatic, Polyposis juvenile intestinal<\/td>\n<td width=\"167\">\u51fa\u8840\u6027\u8840\u7ba1\u64f4\u5f35\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">SMAD6<\/td>\n<td width=\"426\">Aortic valve disease 2, Craniosynostosis 7 susceptibility to<\/td>\n<td width=\"167\">\u9871\u7e2b\u65e9\u9589, \u52d5\u8108\u74e3\u819c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">TGFB2<\/td>\n<td width=\"426\">Loeys-Dietz syndrome 4<\/td>\n<td width=\"167\">Loeys-Dietz \u75c7\u5019\u7fa4<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">TGFB3<\/td>\n<td width=\"426\">Arrhythmogenic right ventricular dysplasia 1, Loeys-Dietz syndrome 5<\/td>\n<td width=\"167\">Loeys-Dietz \u75c7\u5019\u7fa4<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">TGFBR1<\/td>\n<td width=\"426\">Loeys-Dietz syndrome 1, Susceptibility to multiple self-healing squamous epithelioma<\/td>\n<td width=\"167\">\u52d5\u8108\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">TGFBR2<\/td>\n<td width=\"426\">Colorectal cancer hereditary nonpolyposis type 6, Esophageal cancer somatic, Loeys-Dietz syndrome 2<\/td>\n<td width=\"167\">\u52d5\u8108\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">TRAF7<\/td>\n<td width=\"426\">Cardiac, facial, and digital anomalies with developmental delay<\/td>\n<td width=\"167\">\u767c\u80b2\u9072\u7de9\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"78\">ZNF469<\/td>\n<td width=\"426\">Brittle cornea syndrome 1<\/td>\n<td width=\"167\">\u9b06\u76ae\u75c7<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<style type=\"text\/css\"><\/style><div class=\"fusion-title title fusion-title-4 fusion-sep-none fusion-title-text fusion-title-size-one\" style=\"margin-top:0px;margin-right:0px;margin-bottom:0px;margin-left:0px;\"><h1 class=\"title-heading-left fusion-responsive-typography-calculated\" style=\"margin:0;--fontSize:80;line-height:1;\"><h2><\/h2>\n<h2 style=\"text-align: center;\">\u7cd6\u5c3f\u75c5\u548c\u80a5\u80d6\u53ca\u4ee3\u8b1d<\/h2>\n<h2><\/h2><\/h1><\/div>\n<div class=\"table-1\">\n<table style=\"height: 3141px;\" width=\"1061\">\n<tbody>\n<tr>\n<td width=\"76\">\u57fa\u56e0\u540d<\/td>\n<td width=\"425\">\u76f8\u95dc\u75be\u75c5<\/td>\n<td width=\"170\">\u75be\u75c5\u4e2d\u6587\u540d<\/td>\n<\/tr>\n<tr>\n<td width=\"76\">ABCC8<\/td>\n<td width=\"425\">Diabetes mellitus permanent neonatal, Diabetes mellitus noninsulin-dependent, Diabetes mellitus transient neonatal 2, Hyperinsulinemic hypoglycemia familial 1, Hypoglycemia of infancy leucine-sensitive<\/td>\n<td width=\"170\">\u7cd6\u5c3f\u75c5<\/td>\n<\/tr>\n<tr>\n<td width=\"76\">APPL1<\/td>\n<td width=\"425\">Maturity-onset diabetes of the young type 14<\/td>\n<td width=\"170\">\u7cd6\u5c3f\u75c5<\/td>\n<\/tr>\n<tr>\n<td width=\"76\">BLK<\/td>\n<td width=\"425\">Maturity-onset diabetes of the young type 11<\/td>\n<td width=\"170\">\u7cd6\u5c3f\u75c5<\/td>\n<\/tr>\n<tr>\n<td width=\"76\">CEL<\/td>\n<td width=\"425\">Maturity-onset diabetes of the young type VIII<\/td>\n<td width=\"170\">\u7cd6\u5c3f\u75c5<\/td>\n<\/tr>\n<tr>\n<td width=\"76\">DYRK1B<\/td>\n<td width=\"425\">Abdominal obesity-metabolic syndrome 3<\/td>\n<td width=\"170\">\u80a5\u80d6\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"76\">EIF2AK3<\/td>\n<td width=\"425\">Wolcott-Rallison syndrome<\/td>\n<td width=\"170\">Wolcott-Rallison\u75c7\u5019\u7fa4<\/td>\n<\/tr>\n<tr>\n<td width=\"76\">FOXP3<\/td>\n<td width=\"425\">Immunodysregulation polyendocrinopathy and enteropathy X- linked<\/td>\n<td width=\"170\">\u7b2c\u4e00\u578b\u7cd6\u5c3f\u75c5, \u514d\u75ab\u5931\u8abf<\/td>\n<\/tr>\n<tr>\n<td width=\"76\">GATA6<\/td>\n<td width=\"425\">Pancreatic agenesis and congenital heart defects<\/td>\n<td width=\"170\">\u80f0\u81df\u767c\u80b2\u4e0d\u5168, \u5148\u5929\u6027\u5fc3\u81df\u75c5<\/td>\n<\/tr>\n<tr>\n<td width=\"76\">GCK<\/td>\n<td width=\"425\">Diabetes mellitus noninsulin-dependent late onset, Diabetes mellitus permanent neonatal, MODY type II, Hyperinsulinemic hypoglycemia familial 3<\/td>\n<td width=\"170\">\u7cd6\u5c3f\u75c5<\/td>\n<\/tr>\n<tr>\n<td width=\"76\">GLIS3<\/td>\n<td width=\"425\">Diabetes mellitus neonatal with congenital hypothyroidism<\/td>\n<td width=\"170\">\u7cd6\u5c3f\u75c5, \u5148\u5929\u6027\u4f4e\u7532\u72c0\u817a\u7d20\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"76\">HNF1A<\/td>\n<td width=\"425\">Diabetes mellitus insulin-dependent, MODY type III, Hepatic adenoma somatic, Renal cell carcinoma, Diabetes mellitus insulin-dependent 20, Diabetes mellitus noninsulin-dependent 2<\/td>\n<td width=\"170\">\u7cd6\u5c3f\u75c5<\/td>\n<\/tr>\n<tr>\n<td width=\"76\">HNF1B<\/td>\n<td width=\"425\">Diabetes mellitus noninsulin-dependent, Renal cysts and diabetes syndrome<\/td>\n<td width=\"170\">\u7cd6\u5c3f\u75c5<\/td>\n<\/tr>\n<tr>\n<td width=\"76\">HNF4A<\/td>\n<td width=\"425\">Diabetes mellitus noninsulin-dependen, MODY type I, Fanconi renotubular syndrome 4 with maturity-onset diabetes of the young<\/td>\n<td width=\"170\">\u7cd6\u5c3f\u75c5<\/td>\n<\/tr>\n<tr>\n<td width=\"76\">INS<\/td>\n<td width=\"425\">Maturity-onset diabetes of the young type 10, Hyperproinsulinemia, Diabetes mellitus insulin-dependent 2, Diabetes mellitus permanent neonatal<\/td>\n<td width=\"170\">\u7cd6\u5c3f\u75c5<\/td>\n<\/tr>\n<tr>\n<td width=\"76\">KCNJ11<\/td>\n<td width=\"425\">Maturity-onset diabetes of the young type 13, Diabetes mellitus type 2 susceptibility to, Diabetes permanent neonatal with or without neurologic features, Diabetes mellitus transient neonatal 3, Hyperinsulinemic hypoglycemia familial 2<\/td>\n<td width=\"170\">\u7cd6\u5c3f\u75c5<\/td>\n<\/tr>\n<tr>\n<td width=\"76\">KLF11<\/td>\n<td width=\"425\">Maturity-onset diabetes of the young type VII<\/td>\n<td width=\"170\">\u7cd6\u5c3f\u75c5<\/td>\n<\/tr>\n<tr>\n<td width=\"76\">LEP<\/td>\n<td width=\"425\">Obesity morbid due to leptin deficiency<\/td>\n<td width=\"170\">\u80a5\u80d6\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"76\">LEPR<\/td>\n<td width=\"425\">Obesity morbid due to leptin receptor deficiency<\/td>\n<td width=\"170\">\u80a5\u80d6\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"76\">MC4R<\/td>\n<td width=\"425\">Obesity<\/td>\n<td width=\"170\">\u80a5\u80d6\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"76\">NEUROD1<\/td>\n<td width=\"425\">Maturity-onset diabetes of the young 6, Diabetes mellitus noninsulin-dependent<\/td>\n<td width=\"170\">\u5e74\u9752\u4eba\u6210\u5e74\u578b\u7cd6\u5c3f\u75c5, \u7b2c\u4e8c\u578b\u7cd6\u5c3f\u75c5<\/td>\n<\/tr>\n<tr>\n<td width=\"76\">NR0B2<\/td>\n<td width=\"425\">Obesity mild early-onset<\/td>\n<td width=\"170\">\u80a5\u80d6\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"76\">NTRK2<\/td>\n<td width=\"425\">Obesity hyperphagia and developmental delay<\/td>\n<td width=\"170\">\u80a5\u80d6\u75c7, \u767c\u5c55\u9072\u7de9<\/td>\n<\/tr>\n<tr>\n<td width=\"76\">PAX4<\/td>\n<td width=\"425\">Maturity-onset diabetes of the young type IX, Diabetes mellitus type 2, susceptibility to diabetes mellitus ketosis-prone<\/td>\n<td width=\"170\">\u5e74\u9752\u4eba\u6210\u5e74\u578b\u7cd6\u5c3f\u75c5, \u7b2c\u4e8c\u578b\u7cd6\u5c3f\u75c5<\/td>\n<\/tr>\n<tr>\n<td width=\"76\">PCSK1<\/td>\n<td width=\"425\">Obesity susceptibility to BMIQ12, Obesity with impaired prohormone processing<\/td>\n<td width=\"170\">\u80a5\u80d6\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"76\">PDX1<\/td>\n<td width=\"425\">Susceptibility to Diabetes mellitus type II, Pancreatic agenesis 1, MODY type IV<\/td>\n<td width=\"170\">\u7cd6\u5c3f\u75c5, \u80f0\u81df\u767c\u80b2\u4e0d\u5168<\/td>\n<\/tr>\n<tr>\n<td width=\"76\">POMC<\/td>\n<td width=\"425\">Susceptibility to Obesity early-onset, Obesity adrenal insufficiency and red hair due to POMC deficiency<\/td>\n<td width=\"170\">\u80a5\u80d6\u75c7\u53caPOMC\u7f3a\u4e4f\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"76\">PPARG<\/td>\n<td width=\"425\">Diabetes type 2, Insulin resistance severe digenic, Obesity severe, Lipodystrophy familial partial type 3<\/td>\n<td width=\"170\">\u7b2c\u4e8c\u578b\u7cd6\u5c3f\u75c5, \u80a5\u80d6\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"76\">PTF1A<\/td>\n<td width=\"425\">Pancreatic and cerebellar agenesis, Pancreatic agenesis 2<\/td>\n<td width=\"170\">\u7cd6\u5c3f\u75c5, \u80f0\u81df\u53ca\u5c0f\u8166\u767c\u80b2\u4e0d\u5168<\/td>\n<\/tr>\n<tr>\n<td width=\"76\">RFX6<\/td>\n<td width=\"425\">Mitchell-Riley syndrome<\/td>\n<td width=\"170\">Mitchell-riley\u75c7\u5019\u7fa4<\/td>\n<\/tr>\n<tr>\n<td width=\"76\">SIM1<\/td>\n<td width=\"425\">Obesity<\/td>\n<td width=\"170\">\u80a5\u80d6\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"76\">SLC19A2<\/td>\n<td width=\"425\">Thiamine-responsive megaloblastic anemia syndrome<\/td>\n<td width=\"170\">\u7cd6\u5c3f\u75c5, \u8ca7\u8840<\/td>\n<\/tr>\n<tr>\n<td width=\"76\">SLC2A2<\/td>\n<td width=\"425\">Diabetes mellitus noninsulin-dependent, Fanconi-Bickel syndrome<\/td>\n<td width=\"170\">\u975e\u80f0\u5cf6\u7d20\u4f9d\u8cf4\u578b\u7cd6\u5c3f\u75c5<\/td>\n<\/tr>\n<tr>\n<td width=\"76\">UCP3<\/td>\n<td width=\"425\">Obesity severe and type II diabetes<\/td>\n<td width=\"170\">\u80a5\u80d6\u75c7, \u7b2c\u4e8c\u578b\u7cd6\u5c3f\u75c5<\/td>\n<\/tr>\n<tr>\n<td width=\"76\">WFS1<\/td>\n<td width=\"425\">Diabetes mellitus noninsulin-dependent, Wolfram syndrome 1<\/td>\n<td width=\"170\">\u975e\u80f0\u5cf6\u7d20\u4f9d\u8cf4\u578b\u7cd6\u5c3f\u75c5,\u00a0 Wolfram\u6c0f\u75c7\u5019\u7fa4<\/td>\n<\/tr>\n<tr>\n<td width=\"76\">ATP7B<\/td>\n<td width=\"425\">Wilson disease<\/td>\n<td width=\"170\">\u5a01\u723e\u68ee\u6c0f\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"76\">CACNA1S<\/td>\n<td width=\"425\">Malignant hyperthermia susceptibility<\/td>\n<td width=\"170\">\u60e1\u6027\u9ad8\u6eab<\/td>\n<\/tr>\n<tr>\n<td width=\"76\">RYR1<\/td>\n<td width=\"425\">Malignant hyperthermia susceptibility<\/td>\n<td width=\"170\">\u60e1\u6027\u9ad8\u6eab<\/td>\n<\/tr>\n<tr>\n<td width=\"76\">OTC<\/td>\n<td width=\"425\">Ornithine transcarbamylase deficiency<\/td>\n<td width=\"170\">OTC\u7f3a\u4e4f\u75c7<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<style type=\"text\/css\"><\/style><div class=\"fusion-title title fusion-title-5 fusion-sep-none fusion-title-text fusion-title-size-one\" style=\"margin-top:0px;margin-right:0px;margin-bottom:0px;margin-left:0px;\"><h1 class=\"title-heading-left fusion-responsive-typography-calculated\" style=\"margin:0;--fontSize:80;line-height:1;\"><h2><\/h2>\n<h2 style=\"text-align: center;\">\u8996\u89ba\u53ca\u807d\u89ba\u57fa\u56e0<\/h2>\n<h2><\/h2><\/h1><\/div>\n<div class=\"table-1\">\n<table style=\"height: 672px;\" width=\"1090\">\n<tbody>\n<tr>\n<td width=\"85\">\u57fa\u56e0\u540d<\/td>\n<td width=\"425\">\u76f8\u95dc\u75be\u75c5<\/td>\n<td width=\"173\">\u75be\u75c5\u4e2d\u6587\u540d<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">BEST1<\/td>\n<td width=\"425\">Bestrophinopathy<\/td>\n<td width=\"173\">\u8996\u7db2\u819c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">C1QTNF5<\/td>\n<td width=\"425\">Retinal degeneration, late-onset<\/td>\n<td width=\"173\">\u8996\u7db2\u819c\u75c5\u8b8a<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">CTNNA1<\/td>\n<td width=\"425\">Macular dystrophy, patterned, 2<\/td>\n<td width=\"173\">\u9ec3\u6591\u90e8\u767c\u80b2\u4e0d\u5168<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">IMPG1<\/td>\n<td width=\"425\">Macular dystrophy, vitelliform, 4<\/td>\n<td width=\"173\">\u9ec3\u6591\u90e8\u767c\u80b2\u4e0d\u5168<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">IMPG2<\/td>\n<td width=\"425\">Macular dystrophy, vitelliform, 5<\/td>\n<td width=\"173\">\u9ec3\u6591\u90e8\u767c\u80b2\u4e0d\u5168<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">PRPH2<\/td>\n<td width=\"425\">Macular dystrophy, patterned, 1<\/td>\n<td width=\"173\">\u9ec3\u6591\u90e8\u767c\u80b2\u4e0d\u5168<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">COCH<\/td>\n<td width=\"425\">Deafness<\/td>\n<td width=\"173\">\u807d\u89ba\u55aa\u5931<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">EYA4<\/td>\n<td width=\"425\">Deafness<\/td>\n<td width=\"173\">\u807d\u89ba\u55aa\u5931<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">POU4F3<\/td>\n<td width=\"425\">Deafness<\/td>\n<td width=\"173\">\u807d\u89ba\u55aa\u5931<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">SLC17A8<\/td>\n<td width=\"425\">Deafness<\/td>\n<td width=\"173\">\u807d\u89ba\u55aa\u5931<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<style type=\"text\/css\"><\/style><div class=\"fusion-title title fusion-title-6 fusion-sep-none fusion-title-text fusion-title-size-one\" style=\"margin-top:0px;margin-right:0px;margin-bottom:0px;margin-left:0px;\"><h1 class=\"title-heading-left fusion-responsive-typography-calculated\" style=\"margin:0;--fontSize:80;line-height:1;\"><h2><\/h2>\n<h2 style=\"text-align: center;\">\u907a\u50b3\u6027\u75be\u75c5<\/h2>\n<h2><\/h2><\/h1><\/div>\n<div class=\"table-1\">\n<table style=\"height: 1390px;\" width=\"1075\">\n<tbody>\n<tr>\n<td width=\"85\">\u57fa\u56e0\u540d<\/td>\n<td width=\"435\">\u76f8\u95dc\u75be\u75c5<\/td>\n<td width=\"164\">\u75be\u75c5\u4e2d\u6587\u540d<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">CFTR<\/td>\n<td width=\"435\">Cystic Fibrosis<\/td>\n<td width=\"164\">\u56ca\u72c0\u7e96\u7dad\u5316<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">HBB<\/td>\n<td width=\"435\">Beta Hemoglobinopathies (Beta-thalassemia and Sickle Cell)<\/td>\n<td width=\"164\">\u942e\u5200\u578b\u8ca7\u8840<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">NPC1<\/td>\n<td width=\"435\">Niemann-Pick Disease<\/td>\n<td width=\"164\">\u9798\u9ad3\u78f7\u8102\u5132\u7a4d\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">SMPD1<\/td>\n<td width=\"435\">Niemann-Pick Disease<\/td>\n<td width=\"164\">\u9798\u9ad3\u78f7\u8102\u5132\u7a4d\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">GBA<\/td>\n<td width=\"435\">Gaucher Disease<\/td>\n<td width=\"164\">\u9ad8\u96ea\u6c0f\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">HEXA<\/td>\n<td width=\"435\">Tay-Sachs Disease<\/td>\n<td width=\"164\">\u5bb6\u65cf\u6027\u9ed1\u77c7\u7661\u5446\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">DBT<\/td>\n<td width=\"435\">Maple Syrup Urine Disease<\/td>\n<td width=\"164\">\u6953\u7cd6\u5c3f\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">BCKDHA<\/td>\n<td width=\"435\">Maple Syrup Urine Disease<\/td>\n<td width=\"164\">\u6953\u7cd6\u5c3f\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">BCKDHB<\/td>\n<td width=\"435\">Maple Syrup Urine Disease<\/td>\n<td width=\"164\">\u6953\u7cd6\u5c3f\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">G6PC<\/td>\n<td width=\"435\">Glycogen Storage Disease: Type Ia<\/td>\n<td width=\"164\">\u809d\u91a3\u5132\u7a4d\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">PCDH15<\/td>\n<td width=\"435\">Usher Syndrome<\/td>\n<td width=\"164\">\u5c24\u585e\u6c0f\u7d9c\u5408\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">CLRN1<\/td>\n<td width=\"435\">Usher Syndrome<\/td>\n<td width=\"164\">\u5c24\u585e\u6c0f\u7d9c\u5408\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">USH2A<\/td>\n<td width=\"435\">Usher Syndrome<\/td>\n<td width=\"164\">\u5c24\u585e\u6c0f\u7d9c\u5408\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">CDH23<\/td>\n<td width=\"435\">Usher Syndrome<\/td>\n<td width=\"164\">\u5c24\u585e\u6c0f\u7d9c\u5408\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">BLM<\/td>\n<td width=\"435\">Bloom Syndrome<\/td>\n<td width=\"164\">\u5e03\u9686\u6c0f\u75c7\u5019\u7fa4<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">FANCC<\/td>\n<td width=\"435\">Fanconi Anemia<\/td>\n<td width=\"164\">\u8303\u53ef\u5c3c\u6c0f\u8ca7\u8840<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">IKBKAP<\/td>\n<td width=\"435\">Familial Dysautonomia<\/td>\n<td width=\"164\">\u5bb6\u65cf\u6027\u81ea\u4e3b\u795e\u7d93\u5931\u8abf\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">ABCC8<\/td>\n<td width=\"435\">Familial Hyperinsulinism<\/td>\n<td width=\"164\">\u5bb6\u65cf\u6027\u80f0\u5cf6\u7d20\u904e\u591a\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">ASPA<\/td>\n<td width=\"435\">Canavan Disease<\/td>\n<td width=\"164\">\u5361\u7d0d\u842c\u75c5<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">MCOLN1<\/td>\n<td width=\"435\">Mucolipidosis IV<\/td>\n<td width=\"164\">\u9ecf\u8102\u8cea\u75c7<\/td>\n<\/tr>\n<tr>\n<td width=\"85\">TMEM216<\/td>\n<td width=\"435\">Joubert Syndrome<\/td>\n<td width=\"164\">\u5bb6\u65cf\u6027\u5c0f\u8166\u8693\u90e8\u767c\u80b2\u4e0d\u5168<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<div class=\"fusion-clearfix\"><\/div><\/div><\/div><\/div><\/div><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-2 fusion-parallax-fixed nonhundred-percent-fullwidth non-hundred-percent-height-scrolling fusion-equal-height-columns\" style=\"background-color: rgba(255,255,255,0);background-image: url(&quot;https:\/\/geneusmtc.com\/wp-content\/uploads\/2015\/12\/make-an-appointment.jpg&quot;);background-position: center center;background-repeat: no-repeat;padding-top:110px;padding-right:0px;padding-bottom:100px;padding-left:0px;margin-bottom: 0px;margin-top: 0px;border-width: 0px 0px 0px 0px;border-color:#eae9e9;border-style:solid;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;background-attachment:fixed;\" ><div class=\"fusion-builder-row fusion-row\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-1 fusion_builder_column_3_5 3_5 fusion-three-fifth fusion-column-first\" style=\"width:58.4%; margin-right: 4%;margin-top:0px;margin-bottom:30px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 0px 0px;\"><div class=\"fusion-text fusion-text-3\"><h2 class=\"fusion-responsive-typography-calculated\" data-fontsize=\"48\" data-lineheight=\"60px\" data-fusion-font=\"true\"><span style=\"color: #ffffff;\">\u806f\u7d61\u6676\u6e96<\/span><\/h2>\n<\/div><div class=\"fusion-text fusion-text-4\"><p><span style=\"color: #ffffff;\" data-fusion-font=\"true\">\u5c0d\u65bc\u6211\u5011\u7684\u7522\u54c1\u8cc7\u8a0a\u9084\u6709\u7591\u60d1\u55ce\uff1f<\/span><\/p>\n<p><span style=\"color: #ffffff;\" data-fusion-font=\"true\">\u6b61\u8fce\u8a62\u554f\u6211\u5011\u5c08\u696d\u7684\u91ab\u5b78\u5ba2\u670d\u5c08\u54e1\uff0c\u6211\u5011\u6703\u76e1\u5feb\u8207\u60a8\u806f\u7d61\u3002<\/span><\/p>\n<\/div><div class=\"fusion-clearfix\"><\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-2 fusion_builder_column_2_5 2_5 fusion-two-fifth fusion-column-last\" style=\"width:37.6%;margin-top:0px;margin-bottom:30px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 0px 0px;\"><div class=\"fusion-column-content-centered\"><div class=\"fusion-column-content\"><div class=\"fusion-align-block\"><style type=\"text\/css\">.fusion-button.button-1 {border-radius:2px;}<\/style><a class=\"fusion-button button-flat button-xlarge button-default button-1 fusion-button-default-span fusion-button-default-type\" target=\"_self\" href=\"https:\/\/geneusmtc.com\/make-appointment\/\"><span class=\"fusion-button-text\">CONTACT<\/span><\/a><\/div><\/div><\/div><div class=\"fusion-clearfix\"><\/div><\/div><\/div><\/div><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":2441,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v18.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>- \u6676\u6e96\u91ab\u5b78\u79d1\u6280<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/geneusmtc.com\/service\/\u5065\u5eb7\u5148\u77e5\/\" \/>\n<meta property=\"og:locale\" content=\"zh_TW\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"- \u6676\u6e96\u91ab\u5b78\u79d1\u6280\" \/>\n<meta property=\"og:url\" content=\"https:\/\/geneusmtc.com\/service\/\u5065\u5eb7\u5148\u77e5\/\" \/>\n<meta property=\"og:site_name\" content=\"\u6676\u6e96\u91ab\u5b78\u79d1\u6280\" \/>\n<meta property=\"article:modified_time\" content=\"2021-05-14T01:55:06+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"20 \u5206\u9418\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebSite\",\"@id\":\"https:\/\/geneusmtc.com\/#website\",\"url\":\"https:\/\/geneusmtc.com\/\",\"name\":\"\u6676\u6e96\u91ab\u5b78\u79d1\u6280\",\"description\":\"\u5168\u57fa\u56e0\u9ad4\u6aa2\u6e2c\u3001\u5148\u5929\u8207\u5f8c\u5929\u764c\u75c7\u57fa\u56e0\u6aa2\u6e2c\u670d\u52d9\u3001\u65b0\u751f\u5152\u907a\u50b3\u75be\u75c5\u57fa\u56e0\u7be9\u6aa2\u3001\u5b55\u5a66\u975e\u4fb5\u5165\u5f0f\u7522\u524d\u57fa\u56e0\u6aa2\u6e2c\u3001\u5a5a\u524d\u57fa\u56e0\u6aa2\u6e2c\u8207\u85e5\u7269\u57fa\u56e0\u9ad4\u5b78\u6aa2\u6e2c\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/geneusmtc.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"zh-TW\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/geneusmtc.com\/service\/%e5%81%a5%e5%ba%b7%e5%85%88%e7%9f%a5\/#webpage\",\"url\":\"https:\/\/geneusmtc.com\/service\/%e5%81%a5%e5%ba%b7%e5%85%88%e7%9f%a5\/\",\"name\":\"- \u6676\u6e96\u91ab\u5b78\u79d1\u6280\",\"isPartOf\":{\"@id\":\"https:\/\/geneusmtc.com\/#website\"},\"datePublished\":\"2020-04-08T15:00:22+00:00\",\"dateModified\":\"2021-05-14T01:55:06+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/geneusmtc.com\/service\/%e5%81%a5%e5%ba%b7%e5%85%88%e7%9f%a5\/#breadcrumb\"},\"inLanguage\":\"zh-TW\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/geneusmtc.com\/service\/%e5%81%a5%e5%ba%b7%e5%85%88%e7%9f%a5\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/geneusmtc.com\/service\/%e5%81%a5%e5%ba%b7%e5%85%88%e7%9f%a5\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u9996\u9801\",\"item\":\"https:\/\/geneusmtc.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u670d\u52d9\u9805\u76ee\",\"item\":\"https:\/\/geneusmtc.com\/service\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"\"}]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"- \u6676\u6e96\u91ab\u5b78\u79d1\u6280","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/geneusmtc.com\/service\/\u5065\u5eb7\u5148\u77e5\/","og_locale":"zh_TW","og_type":"article","og_title":"- \u6676\u6e96\u91ab\u5b78\u79d1\u6280","og_url":"https:\/\/geneusmtc.com\/service\/\u5065\u5eb7\u5148\u77e5\/","og_site_name":"\u6676\u6e96\u91ab\u5b78\u79d1\u6280","article_modified_time":"2021-05-14T01:55:06+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"20 \u5206\u9418"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebSite","@id":"https:\/\/geneusmtc.com\/#website","url":"https:\/\/geneusmtc.com\/","name":"\u6676\u6e96\u91ab\u5b78\u79d1\u6280","description":"\u5168\u57fa\u56e0\u9ad4\u6aa2\u6e2c\u3001\u5148\u5929\u8207\u5f8c\u5929\u764c\u75c7\u57fa\u56e0\u6aa2\u6e2c\u670d\u52d9\u3001\u65b0\u751f\u5152\u907a\u50b3\u75be\u75c5\u57fa\u56e0\u7be9\u6aa2\u3001\u5b55\u5a66\u975e\u4fb5\u5165\u5f0f\u7522\u524d\u57fa\u56e0\u6aa2\u6e2c\u3001\u5a5a\u524d\u57fa\u56e0\u6aa2\u6e2c\u8207\u85e5\u7269\u57fa\u56e0\u9ad4\u5b78\u6aa2\u6e2c","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/geneusmtc.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"zh-TW"},{"@type":"WebPage","@id":"https:\/\/geneusmtc.com\/service\/%e5%81%a5%e5%ba%b7%e5%85%88%e7%9f%a5\/#webpage","url":"https:\/\/geneusmtc.com\/service\/%e5%81%a5%e5%ba%b7%e5%85%88%e7%9f%a5\/","name":"- \u6676\u6e96\u91ab\u5b78\u79d1\u6280","isPartOf":{"@id":"https:\/\/geneusmtc.com\/#website"},"datePublished":"2020-04-08T15:00:22+00:00","dateModified":"2021-05-14T01:55:06+00:00","breadcrumb":{"@id":"https:\/\/geneusmtc.com\/service\/%e5%81%a5%e5%ba%b7%e5%85%88%e7%9f%a5\/#breadcrumb"},"inLanguage":"zh-TW","potentialAction":[{"@type":"ReadAction","target":["https:\/\/geneusmtc.com\/service\/%e5%81%a5%e5%ba%b7%e5%85%88%e7%9f%a5\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/geneusmtc.com\/service\/%e5%81%a5%e5%ba%b7%e5%85%88%e7%9f%a5\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u9996\u9801","item":"https:\/\/geneusmtc.com\/"},{"@type":"ListItem","position":2,"name":"\u670d\u52d9\u9805\u76ee","item":"https:\/\/geneusmtc.com\/service\/"},{"@type":"ListItem","position":3,"name":""}]}]}},"_links":{"self":[{"href":"https:\/\/geneusmtc.com\/wp-json\/wp\/v2\/pages\/2634"}],"collection":[{"href":"https:\/\/geneusmtc.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/geneusmtc.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/geneusmtc.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/geneusmtc.com\/wp-json\/wp\/v2\/comments?post=2634"}],"version-history":[{"count":0,"href":"https:\/\/geneusmtc.com\/wp-json\/wp\/v2\/pages\/2634\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/geneusmtc.com\/wp-json\/wp\/v2\/pages\/2441"}],"wp:attachment":[{"href":"https:\/\/geneusmtc.com\/wp-json\/wp\/v2\/media?parent=2634"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}